Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the year ended December 31, 2017
Commission File Number 1-11758
(Exact name of Registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation or organization) |
1585 Broadway New York, NY 10036 (Address of principal executive offices, including zip code) |
36-3145972 (I.R.S. Employer Identification No.) |
(212) 761-4000 (Registrants telephone number, including area code) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Name of exchange on which registered | |||
| Common Stock, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate Non-Cumulative Preferred Stock, Series A, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of 6.625% Non-Cumulative Preferred Stock, Series G, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I, $0.01 par value |
New York Stock Exchange | |||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K, $0.01 par value |
New York Stock Exchange | |||
| Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes due 2026 of Morgan Stanley Finance LLC (and Registrants guarantee with respect thereto) | New York Stock Exchange | |||
| Market Vectors ETNs due March 31, 2020 (two issuances); Market Vectors ETNs due April 30, 2020 (two issuances) |
NYSE Arca, Inc. | |||
| Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031 |
NYSE Arca, Inc. |
Indicate by check mark if Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☒ NO ☐
Indicate by check mark if Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES ☐ NO ☒
Indicate by check mark whether Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). YES ☒ NO ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act. (Check one):
| Large Accelerated Filer ☒ |
Accelerated Filer ☐ | |||
| Non-Accelerated Filer ☐ |
Smaller reporting company ☐ | |||
| (Do not check if a smaller reporting company) |
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether Registrant is a shell company (as defined in Exchange Act Rule 12b-2). YES ☐ NO ☒
As of June 30, 2017, the aggregate market value of the common stock of Registrant held by non-affiliates of Registrant was approximately $77,833,014,763. This calculation does not reflect a determination that persons are affiliates for any other purposes.
As of January 31, 2018, there were 1,791,846,388 shares of Registrants common stock, $0.01 par value, outstanding.
Documents Incorporated by Reference: Portions of Registrants definitive proxy statement for its 2018 annual meeting of shareholders are incorporated by reference in Part III of this Form 10-K.
Table of Contents
ANNUAL REPORT ON FORM 10-K
for the year ended December 31, 2017
| Table of Contents | Part | Item | Page | |||||
| I | 1 | 1 | ||||||
| 1 | ||||||||
| 1 | ||||||||
| 1 | ||||||||
| 2 | ||||||||
| 10 | ||||||||
| 1A | 11 | |||||||
| 1B | 22 | |||||||
| 2 | 22 | |||||||
| 3 | 23 | |||||||
| 4 | 28 | |||||||
| II | 5 | 29 | ||||||
| 6 | 31 | |||||||
| Managements Discussion and Analysis of Financial Condition and Results of Operations |
7 | 32 | ||||||
| 32 | ||||||||
| 33 | ||||||||
| 38 | ||||||||
| 52 | ||||||||
| 53 | ||||||||
| 54 | ||||||||
| 57 | ||||||||
| 7A | 71 | |||||||
| 8 | 91 | |||||||
| 91 | ||||||||
| 92 | ||||||||
| 93 | ||||||||
| 94 | ||||||||
| 95 | ||||||||
| 96 | ||||||||
| 97 | ||||||||
| 97 | ||||||||
| 98 | ||||||||
| 109 | ||||||||
| 124 | ||||||||
| 129 | ||||||||
| 133 | ||||||||
| 136 | ||||||||
| 139 | ||||||||
|
|
|
139 | ||||||
i
Table of Contents
| Table of Contents | Part | Item | Page | |||||||
| 140 | ||||||||||
| 140 | ||||||||||
| 142 | ||||||||||
| 13. Variable Interest Entities and Securitization Activities |
148 | |||||||||
| 153 | ||||||||||
| 156 | ||||||||||
| 159 | ||||||||||
| 159 | ||||||||||
| 159 | ||||||||||
| 161 | ||||||||||
| 166 | ||||||||||
| 169 | ||||||||||
| 171 | ||||||||||
| 174 | ||||||||||
| 175 | ||||||||||
| 176 | ||||||||||
| 180 | ||||||||||
| Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
9 | 182 | ||||||||
| 9A | 182 | |||||||||
| 9B | 184 | |||||||||
| III | 10 | 184 | ||||||||
| 11 | 184 | |||||||||
| Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
12 | 184 | ||||||||
| Certain Relationships and Related Transactions and Director Independence |
13 | 185 | ||||||||
| 14 | 185 | |||||||||
| IV | 15 | 185 | ||||||||
| 16 | 185 | |||||||||
| E-1 | ||||||||||
|
|
|
|
|
S-1 | ||||||
ii
Table of Contents
Forward-Looking Statements
We have included in or incorporated by reference into this report, and from time to time may make in our public filings, press releases or other public statements, certain statements, including (without limitation) those under Legal Proceedings, Managements Discussion and Analysis of Financial Condition and Results of Operations and Quantitative and Qualitative Disclosures about Market Risk that may constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, our management may make forward-looking statements to analysts, investors, representatives of the media and others. These forward-looking statements are not historical facts and represent only our beliefs regarding future events, many of which, by their nature, are inherently uncertain and beyond our control.
The nature of our business makes predicting the future trends of our revenues, expenses, and net income difficult. The risks and uncertainties involved in our businesses could affect the matters referred to in such statements, and it is possible that our actual results may differ, possibly materially, from the anticipated results indicated in these forward-looking statements. Important factors that could cause actual results to differ from those in the forward-looking statements include (without limitation):
| | the effect of market conditions, particularly in the global equity, fixed income, currency, credit and commodities markets, including corporate and mortgage (commercial and residential) lending and commercial real estate markets and energy markets; |
| | the level of individual investor participation in the global markets as well as the level of client assets; |
| | the flow of investment capital into or from Assets under management or supervision; |
| | the level and volatility of equity, fixed income and commodity prices, interest rates, currency values and other market indices; |
| | the availability and cost of both credit and capital as well as the credit ratings assigned to our unsecured short-term and long-term debt; |
| | technological changes instituted by us, our competitors or counterparties and technological risks, business continuity and related operational risks; |
| | risk associated with cybersecurity threats, including data protection and cybersecurity risk management; |
| | our ability to manage effectively our capital and liquidity, including approval of our capital plans by our banking regulators; |
| | the impact of current, pending and future legislation (including with respect to the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act)) or changes thereto, regulation (including capital, leverage, funding, liquidity and recovery and resolution requirements and our ability to address such requirements), policies (including fiscal and monetary policies established by central banks and financial regulators, and changes to global trade policies), and other legal and regulatory actions in the U.S. and worldwide; |
| | changes in tax laws and regulations globally, including the interpretation and application of the U.S. Tax Cuts and Jobs Act (Tax Act); |
| | the effectiveness of our risk management policies; |
| | our ability to effectively respond to an economic downturn, or other market disruptions; |
| | the actions and initiatives of current and potential competitors as well as governments, central banks, regulators and self-regulatory organizations; |
| | our ability to provide innovative products and services and execute our strategic objectives; |
| | the effect of economic and political conditions and geopolitical events, including the U.K. anticipated withdrawal from the E.U.; |
| | sovereign risk; |
| | the performance and results of our acquisitions, divestitures, joint ventures, strategic alliances or other strategic arrangements; |
| | investor, consumer and business sentiment and confidence in the financial markets; |
| | our reputation and the general perception of the financial services industry; |
| | inflation, natural disasters, pandemics and acts of war or terrorism; and |
| | other risks and uncertainties detailed under BusinessCompetition and BusinessSupervision and Regulation, Risk Factors and elsewhere throughout this report. |
Accordingly, you are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made. We undertake no obligation to update publicly or revise any forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made, whether as a result of new information, future events or otherwise except as required by applicable law. You should, however, consult further disclosures we may make in future filings of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and any amendments thereto or in future press releases or other public statements.
iii
Table of Contents
Available Information
We file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any document we file with the SEC at the SECs public reference room at 100 F Street, NE, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for information on the public reference room. The SEC maintains an internet site, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC. Our electronic SEC filings are available to the public at the SECs internet site.
Our internet site is www.morganstanley.com. You can access our Investor Relations webpage at www.morganstanley.com/about-us-ir. We make available free of charge, on or through our Investor Relations webpage, our Proxy Statements, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (Exchange Act), as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the SECs internet site, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Exchange Act.
You can access information about our corporate governance at www.morganstanley.com/about-us-governance. Our Corporate Governance webpage includes:
| | Amended and Restated Certificate of Incorporation; |
| | Amended and Restated Bylaws; |
| | Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating and Governance Committee, Operations and Technology Committee, and Risk Committee; |
| | Corporate Governance Policies; |
| | Policy Regarding Corporate Political Activities; |
| | Policy Regarding Shareholder Rights Plan; |
| | Equity Ownership Commitment; |
| | Code of Ethics and Business Conduct; |
| | Code of Conduct; |
| | Integrity Hotline Information; and |
| | Environmental and Social Policies. |
Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer, Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (NYSE) on our internet site. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations, 1585 Broadway, New York, NY 10036 (212-761-4000). The information on our internet site is not incorporated by reference into this report.
iv
Table of Contents
|
| 1 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 2 |
Table of Contents
|
| 3 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 4 |
Table of Contents
|
| 5 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 6 |
Table of Contents
|
| 7 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 8 |
Table of Contents
|
| 9 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 10 |
Table of Contents
|
| 11 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 12 |
Table of Contents
|
| 13 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 14 |
Table of Contents
|
| 15 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 16 |
Table of Contents
|
| 17 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 18 |
Table of Contents
|
| 19 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 20 |
Table of Contents
|
| 21 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 22 |
Table of Contents
|
| 23 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 24 |
Table of Contents
|
| 25 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 26 |
Table of Contents
|
| 27 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 28 |
Table of Contents
|
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Morgan Stanleys common stock trades under the symbol MS on the New York Stock Exchange. As of February 15, 2018, we had 61,442 holders of record; however, we believe the number of beneficial owners of our common stock exceeds this number.
The table below sets forth, for each of the last eight quarters, the high and low sales prices per share of our common stock and the amount of dividends declared per common share by our Board of Directors for such quarter.
| 2017 | 2016 | |||||||||||||||||||||||||||
| High | Low | Dividend Declared per Common Share |
High | Low | Dividend Declared per Common Share |
|||||||||||||||||||||||
| First quarter |
$ | 47.33 | $ | 40.06 | $ | 0.20 | $ | 31.70 | $ | 21.16 | $ | 0.15 | ||||||||||||||||
| Second quarter |
45.98 | 40.43 | 0.20 | 28.29 | 23.11 | 0.15 | ||||||||||||||||||||||
| Third quarter |
48.90 | 43.84 | 0.25 | 32.44 | 24.57 | 0.20 | ||||||||||||||||||||||
| Fourth quarter |
54.25 | 47.42 | 0.25 | 44.04 | 30.96 | 0.20 | ||||||||||||||||||||||
The table below sets forth the information with respect to purchases made by or on behalf of the Firm of its common stock during the fourth quarter of the year ended December 31, 2017.
Issuer Purchases of Equity Securities
| $ in millions, except per share data | Total Number of Shares Purchased |
Average Paid Per |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs1 |
Approximate Dollar Shares That May or Programs |
||||||||||||
| Month #1 (October 1, 2017-October 31, 2017) |
||||||||||||||||
| Share Repurchase Program2 |
4,810,000 | $ | 50.55 | 4,810,000 | $ | 3,507 | ||||||||||
| Employee transactions3 |
312,377 | $ | 48.66 | | $ | | ||||||||||
| Month #2 (November 1, 2017-November 30, 2017) |
||||||||||||||||
| Share Repurchase Program2 |
11,310,000 | $ | 49.29 | 11,310,000 | $ | 2,949 | ||||||||||
| Employee transactions3 |
189,235 | $ | 49.63 | | $ | | ||||||||||
| Month #3 (December 1, 2017-December 31, 2017) |
||||||||||||||||
| Share Repurchase Program2 |
8,531,166 | $ | 52.67 | 8,531,166 | $ | 2,500 | ||||||||||
| Employee transactions3 |
194,165 | $ | 52.78 | | $ | | ||||||||||
| Quarter ended December 31, 2017 |
||||||||||||||||
| Share Repurchase Program2 |
24,651,166 | $ | 50.71 | 24,651,166 | $ | 2,500 | ||||||||||
| Employee transactions3 |
695,777 | $ | 50.08 | | $ | | ||||||||||
| 1. | Share purchases under publicly announced programs are made pursuant to open-market purchases, Rule 10b5-1 plans or privately negotiated transactions (including with employee benefit plans) as market conditions warrant and at prices we deem appropriate and may be suspended at any time. |
| 2. | The Firms Board of Directors has authorized the repurchase of the Firms outstanding stock under a share repurchase program (Share Repurchase Program). The Share Repurchase Program is a program for capital management purposes that considers, among other things, business segment capital needs, as well as equity-based compensation and benefit plan requirements. The Share Repurchase Program has no set expiration or termination date. Share repurchases by the Firm are subject to regulatory approval. On June 28, 2017 the Board of Governors of the Federal Reserve System (Federal Reserve) announced that it did not object to our 2017 capital plan, which included a share repurchase of up to $5.0 billion of the Firms outstanding common stock during the period beginning July 1, 2017 through June 30, 2018. During the quarter ended December 31, 2017, the Firm repurchased approximately $1.25 billion of the Firms outstanding common stock as part of its Share Repurchase Program. For further information, see Liquidity and Capital ResourcesCapital Management. |
| 3. | Includes shares acquired by us in satisfaction of the tax withholding obligations on stock-based awards and the exercise of stock options granted under our stock-based compensation plans. |
| 29 | December 2017 Form 10-K |
Table of Contents
|
Stock Performance Graph
The following graph compares the cumulative total shareholder return (rounded to the nearest whole dollar) of our common stock, the S&P 500 Stock Index and the S&P 500 Financials Sector Index for the last five years. The graph assumes a $100 investment at the closing price on December 31, 2012 and reinvestment of dividends on the respective dividend payment dates without commissions. This graph does not forecast future performance of our common stock.
Cumulative Total Return
December 31, 2012 December 31, 2017
| At December 31, | ||||||||||||||||||||||||
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||||||
| Morgan Stanley |
$ | 100.00 | $ | 165.33 | $ | 206.81 | $ | 172.16 | $ | 234.24 | $ | 296.60 | ||||||||||||
| S&P 500 Stock Index |
100.00 | 132.37 | 150.48 | 152.55 | 170.78 | 208.05 | ||||||||||||||||||
| S&P 500 Financials Sector Index |
100.00 | 135.59 | 156.17 | 153.73 | 188.69 | 228.59 | ||||||||||||||||||
| December 2017 Form 10-K | 30 |
Table of Contents
Table of Contents
Table of Contents
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 34 |
Table of Contents
| Managements Discussion and Analysis |
|
| 35 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 36 |
Table of Contents
| Managements Discussion and Analysis |
|
| 37 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 38 |
Table of Contents
| Managements Discussion and Analysis |
|
| 39 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 40 |
Table of Contents
| Managements Discussion and Analysis |
|
| 41 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 42 |
Table of Contents
| Managements Discussion and Analysis |
|
| 43 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 44 |
Table of Contents
| Managements Discussion and Analysis |
|
| 45 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 46 |
Table of Contents
| Managements Discussion and Analysis |
|
| 47 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 48 |
Table of Contents
| Managements Discussion and Analysis |
|
| 49 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 50 |
Table of Contents
| Managements Discussion and Analysis |
|
| 51 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 52 |
Table of Contents
| Managements Discussion and Analysis |
|
| 53 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 54 |
Table of Contents
| Managements Discussion and Analysis |
|
| 55 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 56 |
Table of Contents
| Managements Discussion and Analysis |
|
| 57 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 58 |
Table of Contents
| Managements Discussion and Analysis |
|
| 59 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 60 |
Table of Contents
| Managements Discussion and Analysis |
|
| 61 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 62 |
Table of Contents
| Managements Discussion and Analysis |
|
| 63 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 64 |
Table of Contents
| Managements Discussion and Analysis |
|
| 65 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 66 |
Table of Contents
| Managements Discussion and Analysis |
|
| 67 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 68 |
Table of Contents
| Managements Discussion and Analysis |
|
| 69 | December 2017 Form 10-K |
Table of Contents
| Managements Discussion and Analysis |
|
| December 2017 Form 10-K | 70 |
Table of Contents
Table of Contents
| Risk Disclosures |
|
| 1. | Committees include Securities Risk Committee, Wealth Management Risk Committee and Investment Management Risk Committee. |
| 2. | Committees include Capital Commitment Committee, Global Large Loan Committee, Equity Underwriting Committee, Leveraged Finance Underwriting Committee, and Municipal Capital Commitment Committee. |
| December 2017 Form 10-K | 72 |
Table of Contents
| Risk Disclosures |
|
| 73 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 74 |
Table of Contents
| Risk Disclosures |
|
| 75 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 76 |
Table of Contents
| Risk Disclosures |
|
| 77 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 78 |
Table of Contents
| Risk Disclosures |
|
| 79 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 80 |
Table of Contents
| Risk Disclosures |
|
| 81 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 82 |
Table of Contents
| Risk Disclosures |
|
| 83 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 84 |
Table of Contents
| Risk Disclosures |
|
| 85 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 86 |
Table of Contents
| Risk Disclosures |
|
Top Ten Country Exposures at December 31, 2017
| $ in millions | Net Inventory1 | Net Counterparty Exposure2 |
Loans | Lending Commitments |
Exposure before Hedges |
Hedges3 | Net Exposure | |||||||||||||||||||||
| Country |
||||||||||||||||||||||||||||
| U.K.: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | (416 | ) | $ | 35 | $ | | $ | | $ | (381 | ) | $ | (357 | ) | $ | (738 | ) | ||||||||||
| Non-sovereigns |
1,301 | 9,753 | 2,429 | 6,748 | 20,231 | (1,929 | ) | 18,302 | ||||||||||||||||||||
| Total |
$ | 885 | $ | 9,788 | $ | 2,429 | $ | 6,748 | $ | 19,850 | $ | (2,286 | ) | $ | 17,564 | |||||||||||||
| Germany: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 4,741 | $ | 783 | $ | | $ | | $ | 5,524 | $ | (828 | ) | $ | 4,696 | |||||||||||||
| Non-sovereigns |
480 | 2,156 | 706 | 3,286 | 6,628 | (1,465 | ) | 5,163 | ||||||||||||||||||||
| Total |
$ | 5,221 | $ | 2,939 | $ | 706 | $ | 3,286 | $ | 12,152 | $ | (2,293 | ) | $ | 9,859 | |||||||||||||
| Japan: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 5,379 | $ | 46 | $ | | $ | | $ | 5,425 | $ | (118 | ) | $ | 5,307 | |||||||||||||
| Non-sovereigns |
421 | 3,292 | | | 3,713 | (114 | ) | 3,599 | ||||||||||||||||||||
| Total |
$ | 5,800 | $ | 3,338 | $ | | $ | | $ | 9,138 | $ | (232 | ) | $ | 8,906 | |||||||||||||
| France: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | (227 | ) | $ | | $ | | $ | | $ | (227 | ) | $ | (50 | ) | $ | (277 | ) | ||||||||||
| Non-sovereigns |
318 | 1,580 | 171 | 3,119 | 5,188 | (792 | ) | 4,396 | ||||||||||||||||||||
| Total |
$ | 91 | $ | 1,580 | $ | 171 | $ | 3,119 | $ | 4,961 | $ | (842 | ) | $ | 4,119 | |||||||||||||
| Brazil: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 3,449 | $ | | $ | | $ | | $ | 3,449 | $ | (12 | ) | $ | 3,437 | |||||||||||||
| Non-sovereigns |
(77 | ) | 205 | 28 | 83 | 239 | (17 | ) | 222 | |||||||||||||||||||
| Total |
$ | 3,372 | $ | 205 | $ | 28 | $ | 83 | $ | 3,688 | $ | (29 | ) | $ | 3,659 | |||||||||||||
| Spain: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | (540 | ) | $ | | $ | | $ | | $ | (540 | ) | $ | | $ | (540 | ) | |||||||||||
| Non-sovereigns |
99 | 235 | 191 | 3,658 | 4,183 | (182 | ) | 4,001 | ||||||||||||||||||||
| Total |
$ | (441 | ) | $ | 235 | $ | 191 | $ | 3,658 | $ | 3,643 | $ | (182 | ) | $ | 3,461 | ||||||||||||
| Australia: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 2,193 | $ | 11 | $ | | $ | | $ | 2,204 | $ | | $ | 2,204 | ||||||||||||||
| Non-sovereigns |
163 | 332 | 168 | 753 | 1,416 | (176 | ) | 1,240 | ||||||||||||||||||||
| Total |
$ | 2,356 | $ | 343 | $ | 168 | $ | 753 | $ | 3,620 | $ | (176 | ) | $ | 3,444 | |||||||||||||
| Canada: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | (332 | ) | $ | 24 | $ | | $ | | $ | (308 | ) | $ | | $ | (308 | ) | |||||||||||
| Non-sovereigns |
334 | 1,555 | 76 | 1,441 | 3,406 | (342 | ) | 3,064 | ||||||||||||||||||||
| Total |
$ | 2 | $ | 1,579 | $ | 76 | $ | 1,441 | $ | 3,098 | $ | (342 | ) | $ | 2,756 | |||||||||||||
| China: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 186 | $ | 211 | $ | | $ | | $ | 397 | $ | (54 | ) | $ | 343 | |||||||||||||
| Non-sovereigns |
994 | 280 | 689 | 449 | 2,412 | (10 | ) | 2,402 | ||||||||||||||||||||
| Total |
$ | 1,180 | $ | 491 | $ | 689 | $ | 449 | $ | 2,809 | $ | (64 | ) | $ | 2,745 | |||||||||||||
| India: |
||||||||||||||||||||||||||||
| Sovereigns |
$ | 1,479 | $ | | $ | | $ | | $ | 1,479 | $ | | $ | 1,479 | ||||||||||||||
| Non-sovereigns |
589 | 545 | | | 1,134 | | 1,134 | |||||||||||||||||||||
| Total |
$ | 2,068 | $ | 545 | $ | | $ | | $ | 2,613 | $ | | $ | 2,613 | ||||||||||||||
| 1. | Net inventory represents exposure to both long and short single-name and index positions (i.e., bonds and equities at fair value and CDS based on a notional amount assuming zero recovery adjusted for any fair value receivable or payable). |
| 2. | Net counterparty exposure (i.e., repurchase transactions, securities lending and OTC derivatives) takes into consideration legally enforceable master netting agreements and collateral. |
| 3. | Amounts represent CDS hedges (purchased and sold) on net counterparty exposure and lending executed by trading desks responsible for hedging counterparty and lending credit risk exposures for us. Amounts are based on the CDS notional amount assuming zero recovery adjusted for any fair value receivable or payable. For a further description of the contractual terms for purchased credit protection and whether they may limit the effectiveness of our hedges, see Credit ExposureDerivatives herein. |
| 87 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 88 |
Table of Contents
| Risk Disclosures |
|
| 89 | December 2017 Form 10-K |
Table of Contents
| Risk Disclosures |
|
| December 2017 Form 10-K | 90 |
Table of Contents
| Financial Statements and Supplementary Data |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Morgan Stanley:
/s/ Deloitte & Touche LLP
New York, New York
February 27, 2018
We have served as the Firms auditor since 1997.
| 91 | December 2017 Form 10-K |
Table of Contents
| Consolidated Income Statements |
|
| in millions, except per share data | 2017 | 2016 | 2015 | |||||||||
| Revenues |
||||||||||||
| Investment banking |
$ | 6,003 | $ | 4,933 | $ | 5,594 | ||||||
| Trading |
11,116 | 10,209 | 10,114 | |||||||||
| Investments |
820 | 160 | 541 | |||||||||
| Commissions and fees |
4,061 | 4,109 | 4,554 | |||||||||
| Asset management |
11,797 | 10,697 | 10,766 | |||||||||
| Other |
848 | 825 | 493 | |||||||||
| Total non-interest revenues |
34,645 | 30,933 | 32,062 | |||||||||
| Interest income |
8,997 | 7,016 | 5,835 | |||||||||
| Interest expense |
5,697 | 3,318 | 2,742 | |||||||||
| Net interest |
3,300 | 3,698 | 3,093 | |||||||||
| Net revenues |
37,945 | 34,631 | 35,155 | |||||||||
| Non-interest expenses |
||||||||||||
| Compensation and benefits |
17,166 | 15,878 | 16,016 | |||||||||
| Occupancy and equipment |
1,329 | 1,308 | 1,382 | |||||||||
| Brokerage, clearing and exchange fees |
2,093 | 1,920 | 1,892 | |||||||||
| Information processing and communications |
1,791 | 1,787 | 1,767 | |||||||||
| Marketing and business development |
609 | 587 | 681 | |||||||||
| Professional services |
2,169 | 2,128 | 2,298 | |||||||||
| Other |
2,385 | 2,175 | 2,624 | |||||||||
| Total non-interest expenses |
27,542 | 25,783 | 26,660 | |||||||||
| Income from continuing operations before income taxes |
10,403 | 8,848 | 8,495 | |||||||||
| Provision for income taxes |
4,168 | 2,726 | 2,200 | |||||||||
| Income from continuing operations |
6,235 | 6,122 | 6,295 | |||||||||
| Income (loss) from discontinued operations, net of income taxes |
(19 | ) | 1 | (16 | ) | |||||||
| Net income |
$ | 6,216 | $ | 6,123 | $ | 6,279 | ||||||
| Net income applicable to noncontrolling interests |
105 | 144 | 152 | |||||||||
| Net income applicable to Morgan Stanley |
$ | 6,111 | $ | 5,979 | $ | 6,127 | ||||||
| Preferred stock dividends and other |
523 | 471 | 456 | |||||||||
| Earnings applicable to Morgan Stanley common shareholders |
$ | 5,588 | $ | 5,508 | $ | 5,671 | ||||||
| Earnings per basic common share |
||||||||||||
| Income from continuing operations |
$ | 3.15 | $ | 2.98 | $ | 2.98 | ||||||
| Income (loss) from discontinued operations |
(0.01 | ) | | (0.01 | ) | |||||||
| Earnings per basic common share |
$ | 3.14 | $ | 2.98 | $ | 2.97 | ||||||
| Earnings per diluted common share |
||||||||||||
| Income from continuing operations |
$ | 3.08 | $ | 2.92 | $ | 2.91 | ||||||
| Income (loss) from discontinued operations |
(0.01 | ) | | (0.01 | ) | |||||||
| Earnings per diluted common share |
$ | 3.07 | $ | 2.92 | $ | 2.90 | ||||||
| Dividends declared per common share |
$ | 0.90 | $ | 0.70 | $ | 0.55 | ||||||
| Average common shares outstanding |
||||||||||||
| Basic |
1,780 | 1,849 | 1,909 | |||||||||
| Diluted |
1,821 | 1,887 | 1,953 | |||||||||
| December 2017 Form 10-K | 92 | See Notes to Consolidated Financial Statements |
Table of Contents
| Consolidated Comprehensive Income Statements |
|
| $ in millions | 2017 | 2016 | 2015 | |||||||||
| Net income |
$ | 6,216 | $ | 6,123 | $ | 6,279 | ||||||
| Other comprehensive income (loss), net of tax: |
||||||||||||
| Foreign currency translation adjustments |
$ | 251 | $ | (11 | ) | $ | (304 | ) | ||||
| Change in net unrealized gains (losses) on available-for-sale securities |
41 | (269 | ) | (246 | ) | |||||||
| Pension, postretirement and other |
(117 | ) | (100 | ) | 138 | |||||||
| Change in net debt valuation adjustment |
(588 | ) | (296 | ) | | |||||||
| Total other comprehensive income (loss) |
$ | (413 | ) | $ | (676 | ) | $ | (412 | ) | |||
| Comprehensive income |
$ | 5,803 | $ | 5,447 | $ | 5,867 | ||||||
| Net income applicable to noncontrolling interests |
105 | 144 | 152 | |||||||||
| Other comprehensive income (loss) applicable to noncontrolling interests |
4 | (1 | ) | (4 | ) | |||||||
| Comprehensive income applicable to Morgan Stanley |
$ | 5,694 | $ | 5,304 | $ | 5,719 | ||||||
| See Notes to Consolidated Financial Statements | 93 | December 2017 Form 10-K |
Table of Contents
| Consolidated Balance Sheets |
|
| $ in millions, except share data | At December 31, |
At December 31, |
||||||
| Assets |
||||||||
| Cash and cash equivalents: |
||||||||
| Cash and due from banks |
$ | 24,816 | $ | 22,017 | ||||
| Interest bearing deposits with banks |
21,348 | 21,364 | ||||||
| Restricted cash |
34,231 | 33,979 | ||||||
| Trading assets at fair value ($169,735 and $152,548 were pledged to various parties) |
298,282 | 262,154 | ||||||
| Investment securities (includes $55,203 and $63,170 at fair value) |
78,802 | 80,092 | ||||||
| Securities purchased under agreements to resell (includes $ and $302 at fair value) |
84,258 | 101,955 | ||||||
| Securities borrowed |
124,010 | 125,236 | ||||||
| Customer and other receivables |
56,187 | 46,460 | ||||||
| Loans: |
||||||||
| Held for investment (net of allowance of $224 and $274) |
92,953 | 81,704 | ||||||
| Held for sale |
11,173 | 12,544 | ||||||
| Goodwill |
6,597 | 6,577 | ||||||
| Intangible assets (net of accumulated amortization of $2,730 and $2,421) |
2,448 | 2,721 | ||||||
| Other assets |
16,628 | 18,146 | ||||||
| Total assets |
$ | 851,733 | $ | 814,949 | ||||
| Liabilities |
||||||||
| Deposits (includes $204 and $63 at fair value) |
$ | 159,436 | $ | 155,863 | ||||
| Trading liabilities at fair value |
131,295 | 128,194 | ||||||
| Securities sold under agreements to repurchase (includes $800 and $729 at fair value) |
56,424 | 54,628 | ||||||
| Securities loaned |
13,592 | 15,844 | ||||||
| Other secured financings (includes $3,863 and $5,041 at fair value) |
11,271 | 11,118 | ||||||
| Customer and other payables |
191,510 | 190,513 | ||||||
| Other liabilities and accrued expenses |
17,157 | 15,896 | ||||||
| Borrowings (includes $46,912 and $39,142 at fair value) |
192,582 | 165,716 | ||||||
| Total liabilities |
773,267 | 737,772 | ||||||
| Commitments and contingent liabilities (see Note 12) |
||||||||
| Equity |
||||||||
| Morgan Stanley shareholders equity: |
||||||||
| Preferred stock |
8,520 | 7,520 | ||||||
| Common stock, $0.01 par value: |
||||||||
| Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,788,086,805 and 1,852,481,601 |
20 | 20 | ||||||
| Additional paid-in capital |
23,545 | 23,271 | ||||||
| Retained earnings |
57,577 | 53,679 | ||||||
| Employee stock trusts |
2,907 | 2,851 | ||||||
| Accumulated other comprehensive income (loss) |
(3,060 | ) | (2,643 | ) | ||||
| Common stock held in treasury at cost, $0.01 par value (250,807,174 and 186,412,378 shares) |
(9,211 | ) | (5,797 | ) | ||||
| Common stock issued to employee stock trusts |
(2,907 | ) | (2,851 | ) | ||||
| Total Morgan Stanley shareholders equity |
77,391 | 76,050 | ||||||
| Noncontrolling interests |
1,075 | 1,127 | ||||||
| Total equity |
78,466 | 77,177 | ||||||
| Total liabilities and equity |
$ | 851,733 | $ | 814,949 | ||||
| December 2017 Form 10-K | 94 | See Notes to Consolidated Financial Statements |
Table of Contents
| Consolidated Statements of Changes in Total Equity |
|
| $ in millions | Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Employee Stock Trusts |
Accumulated Other Comprehensive Income (Loss) |
Common Stock Held in Treasury at Cost |
Common Stock Issued to Employee Stock Trusts |
Non- controlling Interests |
Total Equity |
||||||||||||||||||||||||||||||
| Balance at December 31, 2014 |
$ | 6,020 | $ | 20 | $ | 24,249 | $ | 44,625 | $ | 2,127 | $ | (1,248 | ) | $ | (2,766 | ) | $ | (2,127 | ) | $ | 1,204 | $ | 72,104 | |||||||||||||||||
| Net income applicable to Morgan Stanley |
| | | 6,127 | | | | | | 6,127 | ||||||||||||||||||||||||||||||
| Net income applicable to noncontrolling interests |
| | | | | | | | 152 | 152 | ||||||||||||||||||||||||||||||
| Dividends |
| | | (1,548 | ) | | | | | | (1,548 | ) | ||||||||||||||||||||||||||||
| Shares issued under employee plans and related tax effects |
| | (79 | ) | | 282 | | 1,480 | (282 | ) | | 1,401 | ||||||||||||||||||||||||||||
| Repurchases of common stock and employee tax withholdings |
| | | | | | (2,773 | ) | | | (2,773 | ) | ||||||||||||||||||||||||||||
| Net change in Accumulated other comprehensive income (loss) |
| | | | | (408 | ) | | | (4 | ) | (412 | ) | |||||||||||||||||||||||||||
| Issuance of preferred stock |
1,500 | | (7 | ) | | | | | | | 1,493 | |||||||||||||||||||||||||||||
| Deconsolidation of certain legal entities associated with a real estate fund |
| | | | | | | | (191 | ) | (191 | ) | ||||||||||||||||||||||||||||
| Other net decreases |
| | (10 | ) | | | | | | (159 | ) | (169 | ) | |||||||||||||||||||||||||||
| Balance at December 31, 2015 |
7,520 | 20 | 24,153 | 49,204 | 2,409 | (1,656 | ) | (4,059 | ) | (2,409 | ) | 1,002 | 76,184 | |||||||||||||||||||||||||||
| Cumulative adjustment for accounting change related to DVA1 |
| | | 312 | | (312 | ) | | | | | |||||||||||||||||||||||||||||
| Net adjustment for accounting change related to consolidation2 |
| | | | | | | | 106 | 106 | ||||||||||||||||||||||||||||||
| Net income applicable to Morgan Stanley |
| | | 5,979 | | | | | | 5,979 | ||||||||||||||||||||||||||||||
| Net income applicable to noncontrolling interests |
| | | | | | | | 144 | 144 | ||||||||||||||||||||||||||||||
| Dividends |
| | | (1,816 | ) | | | | | | (1,816 | ) | ||||||||||||||||||||||||||||
| Shares issued under employee plans and related tax effects |
| | (892 | ) | | 442 | | 2,195 | (442 | ) | | 1,303 | ||||||||||||||||||||||||||||
| Repurchases of common stock and employee tax withholdings |
| | | | | | (3,933 | ) | | | (3,933 | ) | ||||||||||||||||||||||||||||
| Net change in Accumulated other comprehensive income (loss) |
| | | | | (675 | ) | | | (1 | ) | (676 | ) | |||||||||||||||||||||||||||
| Other net increases (decreases) |
| | 10 | | | | | | (124 | ) | (114 | ) | ||||||||||||||||||||||||||||
| Balance at December 31, 2016 |
7,520 | 20 | 23,271 | 53,679 | 2,851 | (2,643 | ) | (5,797 | ) | (2,851 | ) | 1,127 | 77,177 | |||||||||||||||||||||||||||
| Cumulative adjustment for accounting changes3 |
| | 45 | (35 | ) | | | | | | 10 | |||||||||||||||||||||||||||||
| Net income applicable to Morgan Stanley |
| | | 6,111 | | | | | | 6,111 | ||||||||||||||||||||||||||||||
| Net income applicable to noncontrolling interests |
| | | | | | | | 105 | 105 | ||||||||||||||||||||||||||||||
| Dividends |
| | | (2,178 | ) | | | | | | (2,178 | ) | ||||||||||||||||||||||||||||
| Shares issued under employee plans |
| | 306 | | 56 | | 878 | (56 | ) | | 1,184 | |||||||||||||||||||||||||||||
| Repurchases of common stock and employee tax withholdings |
| | | | | | (4,292 | ) | | | (4,292 | ) | ||||||||||||||||||||||||||||
| Net change in Accumulated other comprehensive income (loss) |
| | | | | (417 | ) | | | 4 | (413 | ) | ||||||||||||||||||||||||||||
| Issuance of preferred stock |
1,000 | | (6 | ) | | | | | | | 994 | |||||||||||||||||||||||||||||
| Other net decreases |
| | (71 | ) | | | | | | (161 | ) | (232 | ) | |||||||||||||||||||||||||||
| Balance at December 31, 2017 |
$ | 8,520 | $ | 20 | $ | 23,545 | $ | 57,577 | $ | 2,907 | $ | (3,060 | ) | $ | (9,211 | ) | $ | (2,907 | ) | $ | 1,075 | $ | 78,466 | |||||||||||||||||
| 1. | DVArepresents the change in fair value resulting from fluctuations in our credit spreads and other credit factors related to liabilities carried at fair value under the fair value option, primarily related to certain Borrowings (structured notes). In accordance with the early adoption of a provision of the accounting update Recognition and Measurement of Financial Assets and Financial Liabilities, a cumulative catch-up adjustment was recorded as of January 1, 2016 to move the cumulative unrealized DVA amount, net of noncontrolling interests and tax, related to outstanding liabilities under the fair value option election from Retained earnings into AOCI. See Note 15 for further information. |
| 2. | In accordance with the accounting update Amendments to the Consolidation Analysis, a net adjustment was recorded as of January 1, 2016 to both consolidate and deconsolidate certain entities under the new guidance. |
| 3. | The cumulative adjustment relates to the adoption of the following accounting updates on January 1, 2017: Improvements to Employee Share-Based Payment Accounting, for which the Firm recorded a cumulative catch-up adjustment to reflect its election to account for forfeitures as they occur (see Note 2 for further information); and Intra-Entity Transfers of Assets Other Than Inventory, for which the Firm recorded a cumulative catch-up adjustment to reflect the tax impact from an intercompany sale of assets. |
| See Notes to Consolidated Financial Statements | 95 | December 2017 Form 10-K |
Table of Contents
| Consolidated Cash Flow Statements |
|
| $ in millions | 2017 | 2016 | 2015 | |||||||||
| Cash flows from operating activities |
||||||||||||
| Net income |
$ | 6,216 | $ | 6,123 | $ | 6,279 | ||||||
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: |
||||||||||||
| Deferred income taxes |
2,747 | 1,579 | 1,189 | |||||||||
| (Income) loss from equity method investments |
34 | 79 | (114 | ) | ||||||||
| Stock-based compensation expense |
1,026 | 1,136 | 1,104 | |||||||||
| Depreciation and amortization |
1,753 | 1,736 | 1,433 | |||||||||
| Net gain on sale of available-for-sale securities |
(35 | ) | (112 | ) | (84 | ) | ||||||
| Impairment charges |
91 | 130 | 69 | |||||||||
| Provision for credit losses on lending activities |
29 | 144 | 123 | |||||||||
| Other operating adjustments |
63 | (199 | ) | 322 | ||||||||
| Changes in assets and liabilities: |
||||||||||||
| Trading assets, net of Trading liabilities |
(27,588 | ) | (24,079 | ) | 30,212 | |||||||
| Securities borrowed |
1,226 | 17,180 | (5,708 | ) | ||||||||
| Securities loaned |
(2,252 | ) | (3,514 | ) | (5,861 | ) | ||||||
| Customer and other receivables and other assets |
(9,315 | ) | (371 | ) | (434 | ) | ||||||
| Customer and other payables and other liabilities |
2,007 | 1,913 | 4,633 | |||||||||
| Securities purchased under agreements to resell |
17,697 | (14,298 | ) | (4,369 | ) | |||||||
| Securities sold under agreements to repurchase |
1,796 | 17,936 | (33,257 | ) | ||||||||
| Net cash provided by (used for) operating activities |
(4,505 | ) | 5,383 | (4,463 | ) | |||||||
| Cash flows from investing activities |
||||||||||||
| Proceeds from (payments for): |
||||||||||||
| Other assetsPremises, equipment and software, net |
(1,629 | ) | (1,276 | ) | (1,373 | ) | ||||||
| Business dispositions, net of cash disposed |
| | 998 | |||||||||
| Changes in loans, net |
(12,125 | ) | (9,604 | ) | (15,816 | ) | ||||||
| Investment securities: |
||||||||||||
| Purchases |
(23,962 | ) | (50,911 | ) | (47,291 | ) | ||||||
| Proceeds from sales |
18,131 | 33,716 | 37,926 | |||||||||
| Proceeds from paydowns and maturities |
7,445 | 8,367 | 5,663 | |||||||||
| Other investing activities |
(251 | ) | 200 | (102 | ) | |||||||
| Net cash provided by (used for) investing activities |
(12,391 | ) | (19,508 | ) | (19,995 | ) | ||||||
| Cash flows from financing activities |
||||||||||||
| Net proceeds from (payments for): |
||||||||||||
| Noncontrolling interests |
(83 | ) | (96 | ) | (96 | ) | ||||||
| Other secured financings |
(1,573 | ) | 1,333 | (2,370 | ) | |||||||
| Deposits |
3,573 | (171 | ) | 22,490 | ||||||||
| Proceeds from: |
||||||||||||
| Derivatives financing activities |
73 | | 512 | |||||||||
| Issuance of preferred stock, net of issuance costs |
994 | | 1,493 | |||||||||
| Issuance of Borrowings |
55,416 | 43,626 | 34,182 | |||||||||
| Payments for: |
||||||||||||
| Borrowings |
(35,825 | ) | (31,596 | ) | (27,377 | ) | ||||||
| Derivatives financing activities |
(73 | ) | (120 | ) | (452 | ) | ||||||
| Repurchases of common stock and employee tax withholdings |
(4,292 | ) | (3,933 | ) | (2,773 | ) | ||||||
| Cash dividends |
(2,085 | ) | (1,746 | ) | (1,455 | ) | ||||||
| Other financing activities |
136 | 66 | | |||||||||
| Net cash provided by (used for) financing activities |
16,261 | 7,363 | 24,154 | |||||||||
| Effect of exchange rate changes on cash and cash equivalents |
3,670 | (1,430 | ) | (1,735 | ) | |||||||
| Net increase (decrease) in cash and cash equivalents |
3,035 | (8,192 | ) | (2,039 | ) | |||||||
| Cash and cash equivalents, at beginning of period |
77,360 | 85,552 | 87,591 | |||||||||
| Cash and cash equivalents, at end of period |
$ | 80,395 | $ | 77,360 | $ | 85,552 | ||||||
| Cash and cash equivalents: |
||||||||||||
| Cash and due from banks |
$ | 24,816 | $ | 22,017 | $ | 19,827 | ||||||
| Interest bearing deposits with banks |
21,348 | 21,364 | 34,256 | |||||||||
| Restricted cash |
34,231 | 33,979 | 31,469 | |||||||||
| Cash and cash equivalents, at end of period |
$ | 80,395 | $ | 77,360 | $ | 85,552 | ||||||
| Supplemental Disclosure of Cash Flow Information |
||||||||||||
| Cash payments for: |
||||||||||||
| Interest |
$ | 5,377 | $ | 2,834 | $ | 2,672 | ||||||
| Income taxes, net of refunds |
1,390 | 831 | 677 | |||||||||
| December 2017 Form 10-K | 96 | See Notes to Consolidated Financial Statements |
Table of Contents
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 98 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 99 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 100 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 101 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 102 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 103 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 104 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 105 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 106 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 107 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 108 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Fair Value Measurements
Valuation Techniques for Assets and Liabilities Measured at Fair Value on a Recurring Basis
|
Asset and Liability / Valuation Technique |
Valuation Hierarchy Classification |
|||||
| Trading Assets and Trading Liabilities |
||||||
| U.S. Treasury and Agency Securities |
||||||
| U.S. Treasury Securities Fair value is determined using quoted market prices. |
Generally Level 1 |
|||||
| U.S. Agency Securities Non-callable agency-issued debt securities are generally valued using quoted market prices, and callable agency-issued debt securities are valued by benchmarking model-derived prices to quoted market prices and trade data for comparable instruments. The fair value of agency mortgage pass-through pool securities is model-driven based on spreads of comparable to-be-announced securities. CMOs are generally valued using quoted market prices and trade data adjusted by subsequent changes in related indices for comparable instruments. |
Level 1 - non-callable agency-issued debt securities Generally Level 2 - callable agency-issued debt securities, agency mortgage pass-through pool securities and CMOs Level 3 - in instances where the inputs are unobservable |
|||||
| Other Sovereign Government Obligations Fair value is determined using quoted prices in active markets when available. |
Generally Level 1 Level 2 - if the market is less active or prices are dispersed Level 3 - in instances where the prices are unobservable |
|||||
| State and Municipal Securities Fair value is determined using recently executed transactions, market price quotations or pricing models that factor in, where applicable, interest rates, bond or CDS spreads and volatility and/or volatility skew, adjusted for any basis difference between cash and derivative instruments. |
Generally Level 2 if value based on observable market data for comparable instruments |
|||||
| RMBS, CMBS, ABS (collectively known as Mortgage- and Asset-backed securities) Mortgage- and asset-backed securities may be valued based on price or spread data obtained from observed transactions or independent external parties such as vendors or brokers. When position-specific external price data are not observable, the fair value determination may require benchmarking to comparable instruments, and/or analyzing expected credit losses, default and recovery rates, and/or applying discounted cash flow techniques. When evaluating the comparable instruments for use in the valuation of each security, security collateral-specific attributes, including payment priority, credit enhancement levels, type of collateral, delinquency rates and loss severity, are considered. In addition, for RMBS borrowers, FICO scores and the level of documentation for the loan are considered. Market standard models, such as Intex, Trepp or others, may be deployed to model the specific collateral composition and cash flow structure of each transaction. Key inputs to these models are market spreads, forecasted credit losses, and default and prepayment rates for each asset category. Valuation levels of RMBS and CMBS indices are used as an additional data point for benchmarking purposes or to price outright index positions. |
Generally Level 2 - if value based on observable market data for comparable instruments Level 3 - if external prices or significant spread inputs are unobservable or if the comparability assessment involves significant subjectivity related to property type differences, cash flows, performance and other inputs |
|||||
| Corporate Bonds Fair value is determined using recently executed transactions, market price quotations, bond spreads, CDS spreads, or at the money volatility and/or volatility skew obtained from independent external parties, such as vendors and brokers, adjusted for any basis difference between cash and derivative instruments. The spread data used are for the same maturity as the bond. If the spread data do not reference the issuer, then data that reference a comparable issuer are used. When position-specific external price data are not observable, fair value is determined based on either benchmarking to comparable instruments or cash flow models with yield curves, bond or single name CDS spreads and recovery rates as significant inputs. |
Generally Level 2 - if value based on observable market data for comparable instruments Level 3 - in instances where prices or significant spread inputs are unobservable |
|||||
| CDO The Firm holds cash CDOs that typically reference a tranche of an underlying synthetic portfolio of single name CDS spreads collateralized by corporate bonds (CLN) or cash portfolio of ABS/loans (asset-backed CDOs). Credit correlation, a primary input used to determine the fair value of CLNs, is usually unobservable and derived using a benchmarking technique. Other model inputs such as credit spreads, including collateral spreads, and interest rates are typically observable. |
Level 2 - when either comparable market transactions are observable or credit correlation input is insignificant Level 3 - when either comparable market transactions are unobserv- |
| 109 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
|
Asset and Liability / Valuation Technique |
Valuation Hierarchy Classification |
|||||
|
Asset-backed CDOs are valued based on an evaluation of the market and model input parameters sourced from comparable instruments as indicated by market activity. Each asset-backed CDO position is evaluated independently taking into consideration available comparable market levels, underlying collateral performance and pricing, deal structures and liquidity. |
able or the credit correlation input is significant |
|||||
| Loans and Lending Commitments Fair value of corporate loans is determined using recently executed transactions, market price quotations (where observable), implied yields from comparable debt, market observable CDS spread levels obtained from independent external parties adjusted for any basis difference between cash and derivative instruments, along with proprietary valuation models and default recovery analysis where such transactions and quotations are unobservable. Fair value of contingent corporate lending commitments is determined by using executed transactions on comparable loans and the anticipated market price based on pricing indications from syndicate banks and customers. The valuation of loans and lending commitments also takes into account fee income that is considered an attribute of the contract. Fair value of mortgage loans is determined using observable prices based on transactional data or third-party pricing for comparable instruments, when available. Where position-specific external prices are not observable, fair value is estimated based on benchmarking to prices and rates observed in the primary market for similar loan or borrower types or based on the present value of expected future cash flows using its best estimates of the key assumptions, including forecasted credit losses, prepayment rates, forward yield curves and discount rates commensurate with the risks involved or a methodology that utilizes the capital structure and credit spreads of recent comparable securitization transactions. Fair value of equity margin loans is determined by discounting future interest cash flows, net of estimated credit losses. The estimated credit losses are derived by benchmarking to market observable CDS spreads, implied debt yields or volatility metrics of the loan collateral company.
For further information on loans and lending commitments, see Note 7. |
Level 2 - if value based on observable market data for comparable instruments Level 3 - in instances where prices or significant spread inputs are unobservable |
|||||
| Corporate Equities Exchange-traded equity securities are generally valued based on quoted prices from the exchange. To the extent these securities are actively traded, valuation adjustments are not applied. Unlisted equity securities are generally valued based on an assessment of each underlying security, considering rounds of financing and third-party transactions, discounted cash flow analyses and market-based information, including comparable Firm transactions, trading multiples and changes in market outlook, among other factors. Listed fund units are generally marked to the exchange-traded price, while listed fund units if not actively traded and unlisted fund units are generally marked to NAV. |
Level 1 - exchange-traded securities and fund units if actively traded Level 2 - exchange-traded securities if not actively traded or if undergoing a recent mergers and acquisitions event or corporate action Level 3 - unlisted equity securities and exchange-traded securities if not actively traded or if marked to an aged mergers and acquisitions event or corporate action |
|||||
| Derivative and Other Contracts Listed Derivative Contracts Listed derivatives that are actively traded are valued based on quoted prices from the exchange. Listed derivatives that are not actively traded are valued using the same approaches as those applied to OTC derivatives. OTC Derivative Contracts OTC derivative contracts include forward, swap and option contracts related to interest rates, foreign currencies, credit standing of reference entities, equity prices or commodity prices. Depending on the product and the terms of the transaction, the fair value of OTC derivative products can be modeled using a series of techniques, including closed-form analytic formulas, such as the Black-Scholes option-pricing model, simulation models or a combination thereof. Many pricing models do not entail material subjectivity as the methodologies employed do not necessitate significant judgment, since model inputs may be observed from actively quoted markets, as is the case for generic interest rate swaps, many equity, commodity and foreign currency option contracts, and certain CDS. In the case of more established derivative products, the pricing models used by the Firm are widely accepted by the financial services industry. More complex OTC derivative products are typically less liquid and require more judgment in the implementation of the valuation technique since direct trading activity or quotes are unobservable. This includes certain types of interest rate derivatives with both volatility and correlation exposure, equity, commodity or foreign currency derivatives that are either longer-dated or include exposure to multiple underlyings, and credit derivatives, including CDS on certain mortgage- or asset-backed securities and basket CDS. Where these inputs are unobservable, relationships to observ- |
Level 1 - listed derivatives that are actively traded Level 2 - listed derivatives that are not actively traded Generally Level 2 - OTC derivative products valued using observable inputs, or where the unobservable input is not deemed significant Level 3 OTC derivative products for which the unobservable input is deemed significant |
| December 2017 Form 10-K | 110 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
|
Asset and Liability / Valuation Technique |
Valuation Hierarchy Classification |
|||||
| able data points, based on historic and/or implied observations, may be employed as a technique to estimate the model input values.
For further information on the valuation techniques for OTC derivative products, see Note 2. For further information on derivative instruments and hedging activities, see Note 4. |
||||||
| Investments Investments include direct investments in equity securities, as well as various investment management funds, which include investments made in connection with certain employee deferred compensation plans. For direct investments, initially, the transaction price is generally considered by the Firm as the exit price and is its best estimate of fair value. After initial recognition, in determining the fair value of non-exchange-traded internally and externally managed funds, the Firm generally considers the NAV of the fund provided by the fund manager to be the best estimate of fair value. For non-exchange-traded investments either held directly or held within internally managed funds, fair value after initial recognition is based on an assessment of each underlying investment, considering rounds of financing and third-party transactions, discounted cash flow analyses and market-based information, including comparable Firm transactions, trading multiples and changes in market outlook, among other factors. Exchange-traded direct equity investments are generally valued based on quoted prices from the exchange. |
Level 1 - exchange-traded direct equity investments in an active market Level 2 - non-exchange-traded direct equity investments and investments in various investment management funds if valued based on rounds of financing or third-party transactions; exchange-traded direct equity investments if not actively traded Level 3 - non-exchange-traded direct equity investments and investments in various investment management funds where rounds of financing or third-party transactions are not available |
|||||
| Physical Commodities The Firm trades various physical commodities, including natural gas and precious metals. Fair value is determined using observable inputs, including broker quotations and published indices. |
Generally Level 2 if value based on observable inputs |
|||||
| Investment SecuritiesAFS Securities |
||||||
|
AFS securities are composed of U.S. government and agency securities (e.g., U.S. Treasury securities, agency-issued debt, agency mortgage pass-through securities and CMOs), CMBS, FFELP student loan ABS, auto loan ABS, corporate bonds, CLO and actively traded equity securities.
For further information on the determination of fair value, refer to the corresponding asset/liability valuation technique described herein.
For further information on AFS securities, see Note 5. |
For further information on Valuation Hierarchy Classification, see corresponding Valuation Technique described herein. |
|||||
| Deposits |
||||||
| Certificates of Deposit The Firm issues FDIC-insured certificates of deposit that pay either fixed coupons or that have repayment terms linked to the performance of debt or equity securities, indices or currencies. The fair value of these certificates of deposit is determined using valuation models that incorporate observable inputs referencing identical or comparable securities, including prices to which the deposits are linked, interest rate yield curves, option volatility and currency rates, equity prices, and the impact of the Firms own credit spreads, adjusted for the impact of the FDIC insurance, which is based on vanilla deposit issuance rates. |
Generally Level 2 |
|||||
| Securities Purchased under Agreements to Resell and Securities Sold under Agreements to Repurchase |
||||||
|
Fair value is computed using a standard cash flow discounting methodology. The inputs to the valuation include contractual cash flows and collateral funding spreads, which are estimated using various benchmarks, interest rate yield curves and option volatilities. |
Generally Level 2 Level 3 - in instances where the unobservable inputs are deemed significant |
|||||
| Borrowings |
||||||
| Structured Notes The Firm issues structured notes that have coupon or repayment terms linked to the performance of debt or equity securities, indices, currencies or commodities. Fair value of structured notes is determined using valuation models for the derivative and debt portions of the notes. These models incorporate observable inputs referencing identical or comparable securities, including prices to which the notes are linked, interest rate yield curves, option volatility and currency rates, and commodity or equity prices. Independent, external and traded prices for the notes are considered as well. The impact of the Firms own credit spreads is also included based on observed secondary bond market spreads. |
Generally Level 2 Level 3 - in instances where the unobservable inputs are deemed significant |
| 111 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 112 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 113 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for 2017
| $ in millions |
Beginning Balance at December 31, 2016 |
Realized and Unrealized Gains (Losses) |
Purchases1 | Sales and Issuances2 |
Settlements1 | Net Transfers | Ending Balance at December 31, 2017 |
Unrealized Gains (Losses) |
||||||||||||||||||||||||
| Assets at fair value |
||||||||||||||||||||||||||||||||
| Trading assets: |
||||||||||||||||||||||||||||||||
| U.S. Treasury and agency securities |
$ | 74 | $ | (1 | ) | $ | | $ | (240 | ) | $ | | $ | 167 | $ | | $ | | ||||||||||||||
| Other sovereign government obligations |
6 | | | (5 | ) | | | 1 | | |||||||||||||||||||||||
| State and municipal securities |
250 | 3 | 6 | (83 | ) | | (168 | ) | 8 | | ||||||||||||||||||||||
| MABS |
217 | 47 | 289 | (158 | ) | (37 | ) | 65 | 423 | (7 | ) | |||||||||||||||||||||
| Corporate bonds |
232 | 22 | 381 | (218 | ) | | 39 | 456 | (4 | ) | ||||||||||||||||||||||
| CDO |
63 | 22 | 40 | (31 | ) | (9 | ) | (1 | ) | 84 | 15 | |||||||||||||||||||||
| Loans and lending commitments |
5,122 | 182 | 3,616 | (1,561 | ) | (1,463 | ) | 49 | 5,945 | 131 | ||||||||||||||||||||||
| Other debt |
180 | 38 | 66 | (171 | ) | | 48 | 161 | 12 | |||||||||||||||||||||||
| Corporate equities |
446 | (54 | ) | 173 | (632 | ) | | 233 | 166 | (6 | ) | |||||||||||||||||||||
| Net derivative and other contracts3: |
||||||||||||||||||||||||||||||||
| Interest rate |
420 | 322 | 29 | (18 | ) | 608 | (143 | ) | 1,218 | 341 | ||||||||||||||||||||||
| Credit |
(373 | ) | (43 | ) | | (1 | ) | 455 | 3 | 41 | (18 | ) | ||||||||||||||||||||
| Foreign exchange |
(43 | ) | (108 | ) | | (1 | ) | 31 | 9 | (112 | ) | (89 | ) | |||||||||||||||||||
| Equity |
184 | 136 | 988 | (524 | ) | 396 | 28 | 1,208 | 159 | |||||||||||||||||||||||
| Commodity and other |
1,600 | 515 | 24 | (57 | ) | (343 | ) | (293 | ) | 1,446 | 20 | |||||||||||||||||||||
| Total net derivative and other contracts |
1,788 | 822 | 1,041 | (601 | ) | 1,147 | (396 | ) | 3,801 | 413 | ||||||||||||||||||||||
| Investments |
958 | 96 | 102 | (57 | ) | (78 | ) | (1 | ) | 1,020 | 88 | |||||||||||||||||||||
| Liabilities at fair value |
||||||||||||||||||||||||||||||||
| Deposits |
$ | 42 | $ | (3 | ) | $ | | $ | 12 | $ | (3 | ) | $ | (7 | ) | $ | 47 | $ | (3 | ) | ||||||||||||
| Trading liabilities: |
||||||||||||||||||||||||||||||||
| Corporate and other debt |
36 | | (63 | ) | 11 | | 19 | 3 | | |||||||||||||||||||||||
| Corporate equities |
35 | 1 | (76 | ) | 9 | | 55 | 22 | | |||||||||||||||||||||||
| Securities sold under agreements to repurchase |
149 | | | 1 | | | 150 | | ||||||||||||||||||||||||
| Other secured financings |
434 | (35 | ) | | 64 | (251 | ) | (43 | ) | 239 | (28 | ) | ||||||||||||||||||||
| Borrowings |
2,014 | (196 | ) | | 1,968 | (424 | ) | (770 | ) | 2,984 | (173 | ) | ||||||||||||||||||||
| 1. | Loan originations and consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements. |
| 2. | Amounts related to entering into Net derivative and other contracts, Deposits, Other secured financings and Borrowings primarily represent issuances. Amounts for other line items primarily represent sales. |
| 3. | Net derivative and other contracts represent Trading assetsDerivative and other contracts, net of Trading liabilitiesDerivative and other contracts. Amounts are presented before counterparty netting. |
| December 2017 Form 10-K | 114 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for 2016
| $ in millions |
Beginning Balance at December 31, 2015 |
Realized and Unrealized Gains (Losses) |
Purchases1 | Sales and Issuances2 |
Settlements1 | Net Transfers | Ending Balance at December 31, 2016 |
Unrealized Gains (Losses) |
||||||||||||||||||||||||
| Assets at fair value |
||||||||||||||||||||||||||||||||
| Trading assets: |
||||||||||||||||||||||||||||||||
| U.S. Treasury and agency securities |
$ | | $ | (4 | ) | $ | 72 | $ | | $ | | $ | 6 | $ | 74 | $ | (4 | ) | ||||||||||||||
| Other sovereign government obligations |
4 | 1 | 4 | (7 | ) | | 4 | 6 | | |||||||||||||||||||||||
| State and municipal securities |
19 | | 249 | (18 | ) | | | 250 | | |||||||||||||||||||||||
| MABS |
438 | (69 | ) | 82 | (323 | ) | | 89 | 217 | (77 | ) | |||||||||||||||||||||
| Corporate bonds |
267 | 9 | 310 | (357 | ) | | 3 | 232 | (20 | ) | ||||||||||||||||||||||
| CDO |
430 | 11 | 14 | (300 | ) | | (92 | ) | 63 | (5 | ) | |||||||||||||||||||||
| Loans and lending commitments |
5,936 | (79 | ) | 2,261 | (954 | ) | (1,863 | ) | (179 | ) | 5,122 | (80 | ) | |||||||||||||||||||
| Other debt |
448 | 20 | 26 | (51 | ) | | (263 | ) | 180 | (13 | ) | |||||||||||||||||||||
| Corporate equities |
434 | (2 | ) | 242 | (154 | ) | | (74 | ) | 446 | | |||||||||||||||||||||
| Net derivative and other contracts3: |
||||||||||||||||||||||||||||||||
| Interest rate |
260 | 529 | 1 | | (83 | ) | (287 | ) | 420 | 463 | ||||||||||||||||||||||
| Credit |
(844 | ) | (176 | ) | | (4 | ) | 623 | 28 | (373 | ) | (167 | ) | |||||||||||||||||||
| Foreign exchange |
141 | (27 | ) | | | (220 | ) | 63 | (43 | ) | (23 | ) | ||||||||||||||||||||
| Equity |
(2,031 | ) | 539 | 809 | (337 | ) | 1,073 | 131 | 184 | 376 | ||||||||||||||||||||||
| Commodity and other |
1,050 | 544 | 24 | (114 | ) | (44 | ) | 140 | 1,600 | 304 | ||||||||||||||||||||||
| Total net derivative and other contracts |
(1,424 | ) | 1,409 | 834 | (455 | ) | 1,349 | 75 | 1,788 | 953 | ||||||||||||||||||||||
| Investments |
707 | (32 | ) | 398 | (75 | ) | (59 | ) | 19 | 958 | (50 | ) | ||||||||||||||||||||
| Intangible assets |
5 | | | | | (5 | ) | | | |||||||||||||||||||||||
| Liabilities at fair value |
||||||||||||||||||||||||||||||||
| Deposits |
$ | 19 | $ | | $ | | $ | 23 | $ | | $ | | $ | 42 | $ | | ||||||||||||||||
| Trading liabilities: |
||||||||||||||||||||||||||||||||
| Corporate and other debt |
4 | (4 | ) | (99 | ) | 145 | | (18 | ) | 36 | | |||||||||||||||||||||
| Corporate equities |
18 | 17 | (10 | ) | 89 | | (45 | ) | 35 | | ||||||||||||||||||||||
| Securities sold under agreements to repurchase |
151 | 2 | | | | | 149 | 2 | ||||||||||||||||||||||||
| Other secured financings |
461 | (5 | ) | | 79 | (45 | ) | (66 | ) | 434 | (5 | ) | ||||||||||||||||||||
| Borrowings |
1,988 | (19 | ) | | 648 | (305 | ) | (336 | ) | 2,014 | (30 | ) | ||||||||||||||||||||
| 1. | Loan originations and consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements. |
| 2. | Amounts related to entering into Net derivative and other contracts, Deposits, Other secured financings and Borrowings primarily represent issuances. Amounts for other line items primarily represent sales. |
| 3. | Net derivative and other contracts represent Trading assetsDerivative and other contracts, net of Trading liabilitiesDerivative and other contracts. Amounts are presented before counterparty netting. |
| 115 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for 2015
| $ in millions |
Beginning Balance at December 31, 2014 |
Realized and Unrealized Gains (Losses) |
Purchases1 | Sales and Issuances2 |
Settlements1 | Net Transfers | Ending Balance at December 31, 2015 |
Unrealized Gains (Losses) |
||||||||||||||||||||||||
| Assets at fair value |
||||||||||||||||||||||||||||||||
| Trading assets: |
||||||||||||||||||||||||||||||||
| Other sovereign government obligations |
$ | 41 | $ | (1 | ) | $ | 2 | $ | (30 | ) | $ | | $ | (8 | ) | $ | 4 | $ | | |||||||||||||
| State and municipal securities |
| 2 | 3 | | | 14 | 19 | 2 | ||||||||||||||||||||||||
| MABS |
347 | (13 | ) | 226 | (136 | ) | | 14 | 438 | (20 | ) | |||||||||||||||||||||
| Corporate bonds |
386 | (44 | ) | 374 | (381 | ) | (53 | ) | (15 | ) | 267 | (44 | ) | |||||||||||||||||||
| CDOs |
1,152 | 123 | 325 | (798 | ) | (344 | ) | (28 | ) | 430 | (19 | ) | ||||||||||||||||||||
| Loans and lending commitments |
5,874 | (42 | ) | 3,216 | (207 | ) | (2,478 | ) | (427 | ) | 5,936 | (76 | ) | |||||||||||||||||||
| Other debt |
285 | (23 | ) | 131 | (5 | ) | (81 | ) | 141 | 448 | (9 | ) | ||||||||||||||||||||
| Corporate equities |
272 | (1 | ) | 374 | (333 | ) | | 122 | 434 | 11 | ||||||||||||||||||||||
| Net derivative and other contracts3: |
||||||||||||||||||||||||||||||||
| Interest rate |
(173 | ) | (51 | ) | 58 | (54 | ) | 207 | 273 | 260 | 20 | |||||||||||||||||||||
| Credit |
(743 | ) | (172 | ) | 19 | (121 | ) | 196 | (23 | ) | (844 | ) | (179 | ) | ||||||||||||||||||
| Foreign exchange |
151 | 53 | 4 | (2 | ) | (18 | ) | (47 | ) | 141 | 52 | |||||||||||||||||||||
| Equity |
(2,165 | ) | 166 | 81 | (311 | ) | 22 | 176 | (2,031 | ) | 62 | |||||||||||||||||||||
| Commodity and other |
1,146 | 433 | 35 | (222 | ) | (116 | ) | (226 | ) | 1,050 | 402 | |||||||||||||||||||||
| Total net derivative and other contracts |
(1,784 | ) | 429 | 197 | (710 | ) | 291 | 153 | (1,424 | ) | 357 | |||||||||||||||||||||
| Investments |
1,158 | (1 | ) | 33 | (139 | ) | (188 | ) | (156 | ) | 707 | (1 | ) | |||||||||||||||||||
| Intangible assets |
6 | | | | (1 | ) | | 5 | | |||||||||||||||||||||||
| Liabilities at fair value |
||||||||||||||||||||||||||||||||
| Deposits |
$ | | $ | (1 | ) | $ | | $ | 18 | $ | | $ | | $ | 19 | $ | (1 | ) | ||||||||||||||
| Trading liabilities: |
||||||||||||||||||||||||||||||||
| Corporate and other debt |
121 | 5 | (20 | ) | 13 | (104 | ) | (1 | ) | 4 | 5 | |||||||||||||||||||||
| Corporate equities |
45 | 79 | (86 | ) | 33 | | 105 | 18 | 79 | |||||||||||||||||||||||
| Securities sold under agreements to repurchase |
153 | 2 | | | | | 151 | 2 | ||||||||||||||||||||||||
| Other secured financings |
149 | 192 | | 327 | (232 | ) | 409 | 461 | 181 | |||||||||||||||||||||||
| Borrowings |
1,934 | 61 | | 882 | (364 | ) | (403 | ) | 1,988 | 52 | ||||||||||||||||||||||
| 1. | Loan originations and consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements. |
| 2. | Amounts related to entering into Net derivative and other contracts, Deposits, Other secured financings and Borrowings primarily represent issuances. Amounts for other line items primarily represent sales. |
| 3. | Net derivative and other contracts represent Trading assetsDerivative and other contracts, net of Trading liabilitiesDerivative and other contracts. Amounts are presented before counterparty netting. |
| December 2017 Form 10-K | 116 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements
The following disclosures provide information on the valuation techniques, significant unobservable inputs, and their ranges and averages for each major category of assets and liabilities measured at fair value on a recurring and nonrecurring basis with a significant Level 3 balance. The level of aggregation and breadth of products cause the range of inputs to be wide and not evenly distributed across the inventory. Further, the range of unobservable inputs may differ across firms in the financial services industry because of diversity in the types of products included in each firms inventory. There are no predictable relationships between multiple significant unobservable inputs attributable to a given valuation technique. A single amount is disclosed when there is no significant difference between the minimum, maximum and average (weighted average or simple average/median).
Valuation Techniques and Sensitivity of Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements
| Predominant Valuation Techniques/ Significant Unobservable Inputs |
Range (Weighted Average or Simple Average/Median)1 | |||||
| $ in millions, except inputs | At December 31, 2017 | At December 31, 2016 | ||||
| Recurring Fair Value Measurement |
||||||
| Assets at fair value |
||||||
| U.S. Treasury and agency securities ($ and $74) |
||||||
| Comparable pricing: |
Comparable bond price | N/A | 96 to 105 points (102 points) | |||
| State and municipal securities ($8 and $250) |
||||||
| Comparable pricing: |
Comparable bond price | N/M | 53 to 100 points (91 points) | |||
| MABS ($423 and $217) |
||||||
| Comparable pricing: |
Comparable bond price | 0 to 95 points (26 points) | 0 to 86 points (27 points) | |||
| Corporate bonds ($456 and $232) |
||||||
| Comparable pricing: |
Comparable bond price | 3 to 134 points (59 points) | 3 to 130 points (70 points) | |||
| Discounted cash flow: |
Recovery rate | 6% to 36% (27%) | N/A | |||
| CDO ($84 and $63) |
||||||
| Comparable pricing: |
Comparable bond price | 16 to 101 points (67 points) | 0 to 103 points (50 points) | |||
| Loans and lending commitments ($5,945 and $5,122) |
||||||
| Expected recovery: |
Asset coverage | N/M | 43% to 100% (83%) | |||
| Margin loan model: |
Discount rate | 0% to 3% (1%) | 2% to 8% (3%) | |||
| Volatility skew | 7% to 41% (22%) | 21% to 63% (33%) | ||||
| Comparable pricing: |
Comparable loan price | 55 to 102 points (95 points) | 45 to 100 points (84 points) | |||
| Discounted cash flow: |
WACC | N/M | 5% | |||
| Capitalization rate | N/M | 4% to 10% (4%) | ||||
| Other debt ($161 and $180) |
||||||
| Option model: |
At the money volatility | 17% to 52% (52%) | 16% to 52% (52%) | |||
| Discounted cash flow: |
Discount rate | 7% to 20% (14%) | 7% to 12% (11%) | |||
| Comparable pricing: |
Comparable loan price | N/M | 1 to 74 points (23 points) | |||
| Corporate equities ($166 and $446) |
||||||
| Comparable pricing: |
Comparable equity price | 100% | 100% | |||
| Net derivative and other contracts2: |
||||||
| Interest rate ($1,218 and $420) |
||||||
| Option model: |
Interest rate - Foreign exchange correlation | N/M | 28% to 58% (44% / 43%) | |||
| Interest rate volatility skew | 31% to 97% (41% / 47%) | 19% to 117% (55% / 56%) | ||||
| Interest rate quanto correlation | N/M | -17% to 31% (1% / -5%) | ||||
| Interest rate curve correlation | N/M | 28% to 96% (68% / 72%) | ||||
| Inflation volatility | 23% to 63% (44% / 41%) | 23% to 55% (40% / 39%) | ||||
| Interest rate curve | 2% | N/M | ||||
| Credit ($41 and $(373)) |
||||||
| Comparable pricing: |
Cash synthetic basis | 12 to 13 points (12 points) | 5 to 12 points (11 points) | |||
| Comparable bond price | 0 to 75 points (25 points) | 0 to 70 points (23 points) | ||||
| Correlation model: |
Credit correlation | 38% to 100% (48%) | 32% to 70% (45%) | |||
| Foreign exchange3 ($(112) and $(43)) |
||||||
| Option model: |
Interest rate - Foreign exchange correlation | 54% to 57% (56% / 56%) | 28% to 58% (44% / 43%) | |||
| Interest rate volatility skew | 31% to 97% (41% / 47%) | 34% to 117% (55% / 56%) | ||||
| Contingency probability | 95% to 100% (96% / 95%) | N/M | ||||
| Interest rate quanto correlation | N/M | -17% to 31% (1% / -5%) | ||||
| 117 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| Predominant Valuation Techniques/ Significant Unobservable Inputs |
Range (Weighted Average or Simple Average/Median)1 | |||||
| $ in millions, except inputs | At December 31, 2017 | At December 31, 2016 | ||||
| Equity3 ($1,208 and $184) |
||||||
| Option model: |
At the money volatility | 7% to 54% (32%) | 7% to 66% (33%) | |||
| Volatility skew | -5% to 0% (-1%) | -4% to 0% (-1%) | ||||
| Equity - Equity correlation | 5% to 99% (76%) | 25% to 99% (73%) | ||||
| Equity - Foreign exchange correlation | -55% to 40% (36%) | -63% to 30% (-43%) | ||||
| Equity - Interest rate correlation | -7% to 49% (18% / 20%) | -8% to 52% (12% / 4%) | ||||
| Commodity and other ($1,446 and $1,600) |
||||||
| Option model: |
Forward power price | $4 to $102 ($31) per MWh | $7 to $90 ($32) per MWh | |||
| Commodity volatility | 7% to 205% (17%) | 6% to 130% (18%) | ||||
| Cross-commodity correlation | 5% to 99% (92%) | 5% to 99% (92%) | ||||
| Investments ($1,020 and $958) |
||||||
| Discounted cash flow: |
WACC | 8% to 15% (9%) | 10% | |||
| Exit multiple | 8 to 11 times (10 times) | 10 to 24 times (11 times) | ||||
| Market approach: |
EBITDA multiple | 6 to 25 times (11 times) | 6 to 24 times (12 times) | |||
| Comparable pricing: |
Comparable equity price | 45% to 100% (92%) | 75% to 100% (93%) | |||
| Liabilities at Fair Value |
||||||
| Securities sold under agreements to repurchase ($150 and $149) |
||||||
| Discounted cash flow: |
Funding spread | 107 to 126 bps (120 bps) | 118 to 127 bps (121 bps) | |||
| Other secured financings ($239 and $434) |
||||||
| Discounted cash flow: |
Funding spread | 39 to 76 bps (57 bps) | 63 to 92 bps (78 bps) | |||
| Option model: |
Volatility skew | -1% | -1% | |||
| At the money volatility | 10% to 40% (26%) | N/M | ||||
| Discounted cash flow: |
Discount rate | N/M | 4% | |||
| Borrowings ($2,984 and $2,014) |
||||||
| Option model: |
At the money volatility | 5% to 35% (22%) | 7% to 42% (30%) | |||
| Volatility skew | -2% to 0% (0%) | -2% to 0% (-1%) | ||||
| Equity - Equity correlation | 39% to 95% (86%) | 35% to 99% (84%) | ||||
| Equity - Foreign exchange correlation | -55% to 10% (-18%) | -63% to 13% (-40%) | ||||
| Option model: |
Equity volatility discount | N/M | 7% to 11% (10% / 10%) | |||
| Nonrecurring Fair Value Measurement |
||||||
| Assets at fair value |
||||||
| Loans ($924 and $2,443) |
||||||
| Corporate loan model: |
Credit spread | 93 to 563 bps (239 bps) | 90 to 487 bps (208 bps) | |||
| Expected recovery: |
Asset coverage | 95% to 99% (95%) | 73% to 99% (97%) | |||
PointsPercentage of par
| 1. | Amounts represent weighted averages except where simple averages and the median of the inputs are provided when more relevant. |
| 2. | CVA and FVA are included in the balance but excluded from the Valuation Technique(s) and Significant Unobservable Inputs. CVA is a Level 3 input when the underlying counterparty credit curve is unobservable. FVA is a Level 3 input in its entirety given the lack of observability of funding spreads in the principal market. |
| 3. | Includes derivative contracts with multiple risks (i.e., hybrid products). |
| Significant Unobservable Inputs Description | Sensitivity | |||
|
Asset coverageThe ratio of a borrowers underlying pledged assets less applicable costs relative to their outstanding debt (while considering the loans principal and the seniority and security of the loan commitment). |
In general, an increase (decrease) to the asset coverage for an asset would result in a higher (lower) fair value. | |||
|
Capitalization rateThe ratio between net operating income produced by an asset and its market value at the projected disposition date. |
In general, an increase (decrease) to the capitalization rate for an asset would result in a lower (higher) fair value. | |||
|
Cash synthetic basisThe measure of the price differential between cash financial instruments and their synthetic derivative-based equivalents. The range disclosed in the table above signifies the number of points by which the synthetic bond equivalent price is higher than the quoted price of the underlying cash bonds. |
In general, an increase (decrease) to the cash synthetic basis for an asset would result in a lower (higher) fair value. | |||
|
Comparable bond or loan priceA pricing input used when prices for the identical instrument are not available. Significant subjectivity may be involved when fair value is determined using pricing data available for comparable instruments. Valuation using comparable instruments can be done by calculating an implied yield (or spread over a liquid benchmark) from the price of a comparable bond or loan, then adjusting that yield (or spread) to derive a value for the bond or loan. The adjustment to yield (or spread) should account for relevant differences in the bonds or loans such as maturity or credit quality. |
In general, an increase (decrease) to the comparable bond or loan price for an asset would result in a higher (lower) fair value. |
| December 2017 Form 10-K | 118 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| Significant Unobservable Inputs Description | Sensitivity | |||
|
Alternatively, a price-to-price basis can be assumed between the comparable instrument and the bond or loan being valued in order to establish the value of the bond or loan. Additionally, as the probability of default increases for a given bond or loan (i.e., as the bond or loan becomes more distressed), the valuation of that bond or loan will increasingly reflect its expected recovery level assuming default. The decision to use price-to-price or yield/spread comparisons largely reflects trading market convention for the financial instruments in question. Price-to-price comparisons are primarily employed for RMBS, CMBS, ABS, CDOs, CLOs, Other debt, interest rate contracts, foreign exchange contracts, Other secured financings and distressed corporate bonds. Implied yield (or spread over a liquid benchmark) is utilized predominately for non-distressed corporate bonds, loans and credit contracts. |
||||
|
Comparable equity priceA price derived from equity raises, share buybacks and external bid levels, etc. A discount or premium may be included in the fair value estimate. |
In general, an increase (decrease) to the comparable equity price of an asset would result in a higher (lower) fair value. | |||
|
Contingency probabilityProbability associated with the realization of an underlying event upon which the value of an asset is contingent. |
In general, an increase (decrease) to the contingency probability for an asset would result in a higher (lower) fair value. | |||
|
CorrelationA pricing input where the payoff is driven by more than one underlying risk. Correlation is a measure of the relationship between the movement of two variables (i.e., how the change in one variable influences a change in the other variable). Credit correlation, for example, is the factor that describes the relationship between the probability of individual entities to default on obligations and the joint probability of multiple entities to default on obligations. |
In general, an increase (decrease) to the correlation would result in an impact to the fair value, but the magnitude and direction of the impact would depend on whether the Firm is long or short the exposure. | |||
|
Credit spreadThe difference in yield between different securities due to differences in credit quality. The credit spread reflects the additional net yield an investor can earn from a security with more credit risk relative to one with less credit risk. The credit spread of a particular security is often quoted in relation to the yield on a credit risk-free benchmark security or reference rate, typically either U.S. Treasury or LIBOR. |
In general, an increase (decrease) to the credit spread of an asset would result in a lower (higher) fair value. | |||
|
EBITDA multiple / Exit multipleThe ratio of the Enterprise Value to EBITDA, where the Enterprise Value is the aggregate value of equity and debt minus cash and cash equivalents. The EBITDA multiple reflects the value of the company in terms of its full-year EBITDA, whereas the exit multiple reflects the value of the company in terms of its full-year expected EBITDA at exit. Either multiple allows comparison between companies from an operational perspective as the effect of capital structure, taxation and depreciation/amortization is excluded. |
In general, an increase (decrease) to the EBITDA or Exit multiple of an asset would result in a higher (lower) fair value. | |||
|
Funding spreadThe difference between the general collateral rate (which refers to the rate applicable to a broad class of U.S. Treasury issuances) and the specific collateral rate (which refers to the rate applicable to a specific type of security pledged as collateral, such as a municipal bond). Repurchase agreements and certain other secured financings are discounted based on collateral curves. The curves are constructed as spreads over the corresponding OIS or LIBOR curves, with the short end of the curve representing spreads over the corresponding OIS curves and the long end of the curve representing spreads over LIBOR. |
In general, an increase (decrease) to the funding spread of an asset would result in a lower (higher) fair value. | |||
|
WACCThe WACC implied by the current value of equity in a discounted cash flow model. The model assumes that the cash flow assumptions, including projections, are fully reflected in the current equity value, while the debt to equity ratio is held constant. The WACC theoretically represents the required rate of return to debt and equity investors. |
In general, an increase (decrease) to the Implied weighted cost of capital of an asset would result in a lower (higher) fair value. | |||
|
Interest rate curveThe term structure of interest rates (relationship between interest rates and the time to maturity) and a markets measure of future interest rates at the time of observation. An interest rate curve is used to set interest rate and foreign exchange derivative cash flows and is a pricing input used in the discounting of any OTC derivative cash flow. |
In general, an increase (decrease) to the interest rate curve would result in an impact to the fair value, but the magnitude and direction of the impact would depend on whether the Firm is long or short the exposure. | |||
|
Recovery rateAmount expressed as a percentage of par that is expected to be received when a credit event occurs. |
In general, an increase (decrease) to the recovery rate for an asset would result in a higher (lower) fair value. | |||
|
VolatilityThe measure of the variability in possible returns for an instrument given how much that instrument changes in value over time. Volatility is a pricing input for options and, generally, the lower the volatility, the less risky the option. The level of volatility used in the valuation of a particular option depends on a number of factors, including the nature of the risk underlying that option (e.g., the volatility of a particular underlying equity security may be significantly different from that of a particular underlying commodity index), the tenor and the strike price of the option. |
In general, an increase (decrease) to the volatility would result in an impact to the fair value, but the magnitude and direction of the impact would depend on whether the Firm is long or short the exposure. | |||
|
Volatility skewThe measure of the difference in implied volatility for options with identical underliers and expiry dates but with different strikes. The implied volatility for an option with a strike price that is above or below the current price of an underlying asset will typically deviate from the implied volatility for an option with a strike price equal to the current price of that same underlying asset. |
In general, an increase (decrease) to the volatility skew would result in an impact to the fair value, but the magnitude and direction of the impact would depend on whether the Firm is long or short the exposure. |
| 119 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 120 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 121 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Valuation Techniques for Assets and Liabilities Not Measured at Fair Value
| Investment SecuritiesHTM securities Fair value is determined using quoted market prices. |
| Securities purchased under agreements to resell/Securities sold under agreements to repurchase, Securities borrowed/Securities loaned, and Other secured financings Typically longer dated instruments for which the fair value is determined using standard cash flow discounting methodology. The inputs to the valuation include contractual cash flows and collateral funding spreads, which are estimated using various benchmarks and interest rate yield curves. |
| Customer and other receivables For the portion of the customer and other receivables where fair value does not equal carrying value, the fair value is determined using collateral information, historical resolution and recovery rates and employee termination data. The cash flow is then discounted using a market observable spread over LIBOR. |
|
Loans The fair value of consumer and residential real estate loans and lending commitments where position-specific external price data are not observable is determined based on the credit risks of the borrower using a probability of default and loss given default method, discounted at the estimated external cost of funding level. The fair value of corporate loans and lending commitments is determined using recently executed transactions, market price quotations (where observable), implied yields from comparable debt, market observable CDS spread levels along with proprietary valuation models and default recovery analysis where such transactions and quotations are unobservable. |
|
Borrowings The fair value is generally determined based on transactional data or third-party pricing for identical or comparable instruments, when available. Where position-specific external prices are not observable, fair value is determined based on current interest rates and credit spreads for debt instruments with similar terms and maturity. |
|
The carrying value of the remaining assets and liabilities not measured at fair value in the following tables approximate fair value due to their short-term nature. |
| December 2017 Form 10-K | 122 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Financial Instruments Not Measured at Fair Value
| 123 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 124 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 125 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 126 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 127 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Credit Ratings of Reference Obligation and Maturities of Credit Protection Sold
| At December 31, 2017 | ||||||||||||||||||||||||
| Maximum Potential Payout/Notional | Fair Value (Asset)/ Liability |
|||||||||||||||||||||||
| Years to Maturity | ||||||||||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | |||||||||||||||||||
| Single name CDSs |
||||||||||||||||||||||||
| Investment grade |
$ | 39,721 | $ | 42,591 | $ | 18,157 | $ | 8,872 | $ | 109,341 | $ | (1,167 | ) | |||||||||||
| Non-investment grade |
14,213 | 16,293 | 6,193 | 908 | 37,607 | (110 | ) | |||||||||||||||||
| Total single name CDSs |
53,934 | 58,884 | 24,350 | 9,780 | 146,948 | (1,277 | ) | |||||||||||||||||
| Index and basket CDSs |
||||||||||||||||||||||||
| Investment grade |
29,046 | 15,418 | 37,343 | 6,807 | 88,614 | (1,091 | ) | |||||||||||||||||
| Non-investment grade |
5,246 | 7,371 | 32,417 | 9,289 | 54,323 | 408 | ||||||||||||||||||
| Total index and basket CDSs |
34,292 | 22,789 | 69,760 | 16,096 | 142,937 | (683 | ) | |||||||||||||||||
| Total CDSs sold |
$ | 88,226 | $ | 81,673 | $ | 94,110 | $ | 25,876 | $ | 289,885 | $ | (1,960 | ) | |||||||||||
| Other credit contracts |
2 | | | 134 | 136 | 16 | ||||||||||||||||||
| Total credit derivatives and other credit contracts |
$ | 88,228 | $ | 81,673 | $ | 94,110 | $ | 26,010 | $ | 290,021 | $ | (1,944 | ) | |||||||||||
| At December 31, 2016 | ||||||||||||||||||||||||
| Maximum Potential Payout/Notional | Fair Value (Asset)/ Liability |
|||||||||||||||||||||||
| Years to Maturity | ||||||||||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | |||||||||||||||||||
| Single name CDSs |
||||||||||||||||||||||||
| Investment grade |
$ | 79,449 | $ | 70,796 | $ | 34,529 | $ | 10,293 | $ | 195,067 | $ | (1,060 | ) | |||||||||||
| Non-investment grade |
34,571 | 25,820 | 10,436 | 1,024 | 71,851 | 307 | ||||||||||||||||||
| Total single name CDSs |
$ | 114,020 | $ | 96,616 | $ | 44,965 | $ | 11,317 | $ | 266,918 | $ | (753 | ) | |||||||||||
| Index and basket CDSs |
||||||||||||||||||||||||
| Investment grade |
$ | 26,530 | $ | 21,388 | $ | 35,060 | $ | 9,096 | $ | 92,074 | $ | (846 | ) | |||||||||||
| Non-investment grade |
26,135 | 22,983 | 11,759 | 9,861 | 70,738 | 550 | ||||||||||||||||||
| Total index and basket CDSs |
$ | 52,665 | $ | 44,371 | $ | 46,819 | $ | 18,957 | $ | 162,812 | $ | (296 | ) | |||||||||||
| Total CDSs sold |
$ | 166,685 | $ | 140,987 | $ | 91,784 | $ | 30,274 | $ | 429,730 | $ | (1,049 | ) | |||||||||||
| Other credit contracts |
49 | 6 | | 215 | 270 | | ||||||||||||||||||
| Total credit derivatives and other credit contracts |
$ | 166,734 | $ | 140,993 | $ | 91,784 | $ | 30,489 | $ | 430,000 | $ | (1,049 | ) | |||||||||||
| December 2017 Form 10-K | 128 |
Table of Contents
Table of Contents
| Notes to Consolidated Financial Statements |
|
Investment Securities in an Unrealized Loss Position
| At December 31, 2017 | ||||||||||||||||||||||||
| Less than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||
| $ in millions | Fair Value | Gross Unrealized Losses |
Fair Value | Gross Unrealized Losses |
Fair Value | Gross Unrealized Losses |
||||||||||||||||||
| AFS debt securities |
||||||||||||||||||||||||
| U.S. government and agency securities: |
||||||||||||||||||||||||
| U.S. Treasury securities |
$ | 21,941 | $ | 495 | $ | 4,287 | $ | 94 | $ | 26,228 | $ | 589 | ||||||||||||
| U.S. agency securities |
12,673 | 192 | 2,513 | 55 | 15,186 | 247 | ||||||||||||||||||
| Total U.S. government and agency securities |
34,614 | 687 | 6,800 | 149 | 41,414 | 836 | ||||||||||||||||||
| Corporate and other debt: |
||||||||||||||||||||||||
| CMBS: |
||||||||||||||||||||||||
| Agency |
930 | 49 | | | 930 | 49 | ||||||||||||||||||
| Non-agency |
257 | 1 | 559 | 7 | 816 | 8 | ||||||||||||||||||
| Corporate bonds |
316 | 3 | 389 | 9 | 705 | 12 | ||||||||||||||||||
| FFELP student loan ABS |
984 | 7 | | | 984 | 7 | ||||||||||||||||||
| Total corporate and other debt |
2,487 | 60 | 948 | 16 | 3,435 | 76 | ||||||||||||||||||
| Total AFS debt securities |
37,101 | 747 | 7,748 | 165 | 44,849 | 912 | ||||||||||||||||||
| AFS equity securities |
| | 5 | 10 | 5 | 10 | ||||||||||||||||||
| Total AFS securities |
37,101 | 747 | 7,753 | 175 | 44,854 | 922 | ||||||||||||||||||
| HTM securities |
||||||||||||||||||||||||
| U.S. government and agency securities: |
||||||||||||||||||||||||
| U.S. Treasury securities |
6,608 | 86 | 4,512 | 219 | 11,120 | 305 | ||||||||||||||||||
| U.S. agency securities |
2,879 | 24 | 7,298 | 196 | 10,177 | 220 | ||||||||||||||||||
| Total U.S. government and agency securities |
9,487 | 110 | 11,810 | 415 | 21,297 | 525 | ||||||||||||||||||
| Corporate and other debt: |
||||||||||||||||||||||||
| CMBS: |
||||||||||||||||||||||||
| Non-agency |
124 | 1 | | | 124 | 1 | ||||||||||||||||||
| Total corporate and other debt |
124 | 1 | | | 124 | 1 | ||||||||||||||||||
| Total HTM securities |
9,611 | 111 | 11,810 | 415 | 21,421 | 526 | ||||||||||||||||||
| Total investment securities |
$ | 46,712 | $ | 858 | $ | 19,563 | $ | 590 | $ | 66,275 | $ | 1,448 | ||||||||||||
| December 2017 Form 10-K | 130 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| At December 31, 2016 | ||||||||||||||||||||||||
| Less than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||
| $ in millions | Fair Value | Gross Unrealized Losses |
Fair Value | Gross Unrealized Losses |
Fair Value | Gross Unrealized Losses |
||||||||||||||||||
| AFS debt securities |
||||||||||||||||||||||||
| U.S. government and agency securities: |
||||||||||||||||||||||||
| U.S. Treasury securities |
$ | 25,323 | $ | 545 | $ | | $ | | $ | 25,323 | $ | 545 | ||||||||||||
| U.S. agency securities |
16,760 | 278 | 125 | | 16,885 | 278 | ||||||||||||||||||
| Total U.S. government and agency securities |
42,083 | 823 | 125 | | 42,208 | 823 | ||||||||||||||||||
| Corporate and other debt: |
||||||||||||||||||||||||
| CMBS: |
||||||||||||||||||||||||
| Agency |
1,245 | 44 | | | 1,245 | 44 | ||||||||||||||||||
| Non-agency |
763 | 11 | 594 | 5 | 1,357 | 16 | ||||||||||||||||||
| Auto loan ABS |
659 | 1 | 123 | | 782 | 1 | ||||||||||||||||||
| Corporate bonds |
2,050 | 21 | 142 | 1 | 2,192 | 22 | ||||||||||||||||||
| CLO |
178 | | 239 | 1 | 417 | 1 | ||||||||||||||||||
| FFELP student loan ABS |
2,612 | 61 | | | 2,612 | 61 | ||||||||||||||||||
| Total corporate and other debt |
7,507 | 138 | 1,098 | 7 | 8,605 | 145 | ||||||||||||||||||
| Total AFS debt securities |
49,590 | 961 | 1,223 | 7 | 50,813 | 968 | ||||||||||||||||||
| AFS equity securities |
6 | 9 | | | 6 | 9 | ||||||||||||||||||
| Total AFS securities |
49,596 | 970 | 1,223 | 7 | 50,819 | 977 | ||||||||||||||||||
| HTM securities |
||||||||||||||||||||||||
| U.S. government and agency securities: |
||||||||||||||||||||||||
| U.S. Treasury securities |
5,057 | 283 | | | 5,057 | 283 | ||||||||||||||||||
| U.S. agency securities |
10,612 | 188 | | | 10,612 | 188 | ||||||||||||||||||
| Total HTM securities |
15,669 | 471 | | | 15,669 | 471 | ||||||||||||||||||
| Total investment securities |
$ | 65,265 | $ | 1,441 | $ | 1,223 | $ | 7 | $ | 66,488 | $ | 1,448 | ||||||||||||
| 131 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Investment Securities by Contractual Maturity
| December 2017 Form 10-K | 132 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 133 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 134 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 135 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 136 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 137 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 138 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 139 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 140 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 141 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 142 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 143 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 144 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 145 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 146 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 147 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 148 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 149 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 150 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 151 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 152 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 153 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 154 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 155 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 156 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
Preferred Stock Issuance Description
| Series | Issuance Date | Preferred Stock Issuance Description | Redemption per Share1 |
Redeemable on or after Date |
Dividend per Share2 |
|||||||||||
| A3 |
July 2006 | 44,000,000 Depositary Shares, each representing a 1/1,000th of a share of Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | $ | 25,000 | July 15, 2011 | $ | 255.56 | |||||||||
|
C3, 4 |
October 13, 2008 | 10% Perpetual Non-Cumulative Non-Voting Preferred Stock | 1,100 | October 15, 2011 | 25.00 | |||||||||||
| E5 |
September 30, 2013 | 34,500,000 Depositary Shares, each representing a 1/1,000th interest in a share of perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | October 15, 2023 | 445.31 | |||||||||||
| F5 |
December 10, 2013 | 34,000,000 Depositary Shares, each representing a 1/1,000th interest in a share of perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | January 15, 2024 | 429.69 | |||||||||||
| G5 |
April 29, 2014 | 20,000,000 Depositary Shares, each representing a 1/1,000th interest in a share of perpetual 6.625% Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | July 15, 2019 | 414.06 | |||||||||||
| H5, 6 |
April 29, 2014 | 1,300,000 Depositary Shares, each representing a 1/25th interest in a share of perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | July 15, 2019 | 681.25 | |||||||||||
| I5 |
September 18, 2014 | 40,000,000 Depositary Shares, each representing a 1/1,000th interest in a share of perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | October 15, 2024 | 398.44 | |||||||||||
| J5, 7 |
March 19, 2015 | 1,500,000 Depositary Shares, each representing a 1/25th interest in a share of perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value | 25,000 | July 15, 2020 | 693.75 | |||||||||||
| K5, 8 |
January 2017 | 40,000,000 Depositary Shares, each representing a 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K, $0.01 par value | 25,000 | April 15, 2027 | 365.63 | |||||||||||
| 1. | The redemption price per share for Series A, E, F, G, I and K is equivalent to $25.00 per Depositary Share. The redemption price per share for Series H and J is equivalent to $1,000 per Depositary Share. |
| 2. | Quarterly dividends (unless noted otherwise). |
| 3. | The preferred stock is redeemable at the Firms option, in whole or in part, on or after the redemption date. |
| 4. | Dividends on the Series C preferred stock are payable, on a non-cumulative basis, as and if declared by the Board, in cash, at the rate of 10% per annum of the liquidation preference of $1,000 per share. |
| 5. | The preferred stock is redeemable at the Firms option (i) in whole or in part, from time to time, on any dividend payment date on or after the redemption date or (ii) in whole but not in part at any time within 90 days following a regulatory capital treatment event (as described in the terms of that series). |
| 6. | Dividend on Series H preferred stock is payable semiannually until July 15, 2019 and quarterly thereafter. |
| 7. | Dividend on Series J preferred stock is payable semiannually until July 15, 2020 and quarterly thereafter. In addition to the redemption price per share, the redemption price includes any declared and unpaid dividends up to, but excluding, the date fixed for redemption, without accumulation of any undeclared dividends. |
| 8. | The Series K Preferred Stock offering (net of related issuance costs) in January 2017 resulted in proceeds of approximately $994 million. |
| 157 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 158 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 159 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 160 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 161 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 162 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 163 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 164 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 165 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 166 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 167 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 168 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 169 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 170 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 171 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 172 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 173 | December 2017 Form 10-K |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| December 2017 Form 10-K | 174 |
Table of Contents
| Notes to Consolidated Financial Statements |
|
| 175 | December 2017 Form 10-K |
Table of Contents
| Financial Data Supplement (Unaudited) Average Balances and Interest Rates and Net Interest Income |
|
| 2017 | 2016 | 2015 | ||||||||||||||||||||||||||||||||||
| $ in millions | Average Daily Balance |
Interest | Average Rate |
Average Daily |
Interest | Average Rate |
Average Daily |
Interest | Average Rate |
|||||||||||||||||||||||||||
| Interest earning assets1 |
||||||||||||||||||||||||||||||||||||
| Investment securities2 |
$ | 76,746 | $ | 1,334 | 1.7 | % | $ | 78,562 | $ | 1,142 | 1.5 | % | $ | 67,993 | $ | 876 | 1.3% | |||||||||||||||||||
| Loans2 |
98,727 | 3,298 | 3.3 | 89,875 | 2,724 | 3.0 | 75,110 | 2,163 | 2.9 | |||||||||||||||||||||||||||
| Securities purchased under agreements to resell and Securities borrowed3: |
||||||||||||||||||||||||||||||||||||
| U.S. |
125,453 | 606 | 0.5 | 144,744 | (172 | ) | (0.1 | ) | 172,481 | (618 | ) | (0.4) | ||||||||||||||||||||||||
| Non-U.S. |
95,478 | (437 | ) | (0.5 | ) | 86,622 | (202 | ) | (0.2 | ) | 80,490 | 58 | 0.1 | |||||||||||||||||||||||
| Trading assets, net of Trading liabilities4: |
||||||||||||||||||||||||||||||||||||
| U.S. |
59,335 | 1,876 | 3.2 | 49,746 | 1,894 | 3.8 | 41,934 | 1,874 | 4.5 | |||||||||||||||||||||||||||
| Non-U.S. |
4,326 | 153 | 3.5 | 12,843 | 237 | 1.8 | 17,267 | 388 | 2.2 | |||||||||||||||||||||||||||
| Customer receivables and Other5: |
||||||||||||||||||||||||||||||||||||
| U.S. |
68,760 | 1,614 | 2.3 | 72,725 | 1,080 | 1.5 | 79,418 | 934 | 1.2 | |||||||||||||||||||||||||||
| Non-U.S. |
27,801 | 553 | 2.0 | 23,874 | 313 | 1.3 | 27,955 | 160 | 0.6 | |||||||||||||||||||||||||||
| Total |
$ | 556,626 | $ | 8,997 | 1.6 | % | $ | 558,991 | $ | 7,016 | 1.3 | % | $ | 562,648 | $ | 5,835 | 1.0% | |||||||||||||||||||
| Interest bearing liabilities1 |
|
|||||||||||||||||||||||||||||||||||
|
Deposits2 |
$ | 151,442 | $ | 187 | 0.1 | % | $ | 155,143 | $ | 83 | 0.1 | % | $ | 141,502 | $ | 78 | 0.1% | |||||||||||||||||||
| Borrowings2, 6 |
184,453 | 4,285 | 2.3 | 163,647 | 3,606 | 2.2 | 159,781 | 3,497 | 2.2 | |||||||||||||||||||||||||||
| Securities sold under agreements to repurchase and Securities loaned7: |
||||||||||||||||||||||||||||||||||||
| U.S. |
30,866 | 900 | 2.9 | 32,359 | 555 | 1.7 | 51,115 | 437 | 0.9 | |||||||||||||||||||||||||||
| Non-U.S. |
39,396 | 337 | 0.9 | 31,491 | 422 | 1.3 | 34,306 | 587 | 1.7 | |||||||||||||||||||||||||||
| Customer payables and Other8: |
||||||||||||||||||||||||||||||||||||
| U.S. |
128,274 | (213 | ) | (0.2 | ) | 114,606 | (1,187 | ) | (1.0 | ) | 120,100 | (1,529 | ) | (1.3) | ||||||||||||||||||||||
| Non-U.S. |
65,496 | 201 | 0.3 | 76,096 | (161 | ) | (0.2 | ) | 67,663 | (328 | ) | (0.5) | ||||||||||||||||||||||||
| Total |
$ | 599,927 | $ | 5,697 | 0.9 | % | $ | 573,342 | $ | 3,318 | 0.6 | % | $ | 574,467 | $ | 2,742 | 0.5% | |||||||||||||||||||
| Net interest income and net interest rate spread |
$ | 3,300 | 0.7 | % | $ | 3,698 | 0.7 | % | $ | 3,093 | 0.5% | |||||||||||||||||||||||||
| 1. | Prior period amounts have been revised to conform to the current presentation. |
| 2. | Amounts include primarily U.S. balances. |
| 3. | Includes fees paid on Securities borrowed. |
| 4. | Trading assets, net of Trading liabilities exclude non-interest earning assets and non-interest bearing liabilities, such as equity securities. |
| 5. | Includes interest from Customer receivables, Restricted cash and Interest bearing deposits with banks. |
| 6. | The Firm also issues structured notes that have coupon or repayment terms linked to the performance of debt or equity securities, indices, currencies or commodities, which are recorded within Trading revenues (see Note 3 to the financial statements). |
| 7. | Includes fees received on Securities loaned. |
| 8. | Includes fees received from prime brokerage customers for stock loan transactions incurred to cover customers short positions. |
| December 2017 Form 10-K | 176 |
Table of Contents
| Financial Data Supplement (Unaudited) Rate/Volume Analysis |
|
Effect of Volume and Rate Changes on Net Interest Income
| 2017 versus 2016 | 2016 versus 2015 | |||||||||||||||||||||||
| Increase (Decrease) Due to Change in: |
Increase (Decrease) Due to Change in: |
|||||||||||||||||||||||
| $ in millions | Volume | Rate | Net Change | Volume | Rate | Net Change | ||||||||||||||||||
| Interest earning assets |
|
|||||||||||||||||||||||
| Investment securities |
$ | (26 | ) | $ | 218 | $ | 192 | $ | 136 | $ | 130 | $ | 266 | |||||||||||
| Loans |
268 | 306 | 574 | 426 | 135 | 561 | ||||||||||||||||||
| Securities purchased under agreements |
|
|||||||||||||||||||||||
| U.S. |
23 | 755 | 778 | 99 | 347 | 446 | ||||||||||||||||||
| Non-U.S. |
(21 | ) | (214 | ) | (235 | ) | 4 | (264 | ) | (260) | ||||||||||||||
| Trading assets, net of Trading liabilities: |
||||||||||||||||||||||||
| U.S. |
365 | (383 | ) | (18 | ) | 349 | (329 | ) | 20 | |||||||||||||||
| Non-U.S. |
(157 | ) | 73 | (84 | ) | (99 | ) | (52 | ) | (151) | ||||||||||||||
| Customer receivables and Other: |
|
|||||||||||||||||||||||
| U.S. |
(59 | ) | 593 | 534 | (79 | ) | 225 | 146 | ||||||||||||||||
| Non-U.S. |
51 | 189 | 240 | (23 | ) | 176 | 153 | |||||||||||||||||
| Change in interest income |
$ | 444 | $ | 1,537 | $ | 1,981 | $ | 813 | $ | 368 | $ | 1,181 | ||||||||||||
| Interest bearing liabilities |
|
|||||||||||||||||||||||
| Deposits |
$ | (2 | ) | $ | 106 | $ | 104 | $ | 8 | $ | (3 | ) | $ | 5 | ||||||||||
| Borrowings |
458 | 221 | 679 | 85 | 24 | 109 | ||||||||||||||||||
| Securities sold under agreements to repurchase and Securities loaned: |
||||||||||||||||||||||||
| U.S. |
(26 | ) | 371 | 345 | (160 | ) | 278 | 118 | ||||||||||||||||
| Non-U.S. |
106 | (191 | ) | (85 | ) | (48 | ) | (117 | ) | (165) | ||||||||||||||
| Customer payables and Other: |
|
|||||||||||||||||||||||
| U.S. |
(142 | ) | 1,116 | 974 | 70 | 272 | 342 | |||||||||||||||||
| Non-U.S. |
22 | 340 | 362 | (41 | ) | 208 | 167 | |||||||||||||||||
| Change in interest expense |
$ | 416 | $ | 1,963 | $ | 2,379 | $ | (86 | ) | $ | 662 | $ | 576 | |||||||||||
| Change in net interest income |
$ | 28 | $ | (426 | ) | $ | (398 | ) | $ | 899 | $ | (294 | ) | $ | 605 | |||||||||
| 177 | December 2017 Form 10-K |
Table of Contents
| Financial Data Supplement (Unaudited)(Continued) |
|
| December 2017 Form 10-K | 178 |
Table of Contents
| Financial Data Supplement (Unaudited)(Continued) |
|
| 179 | December 2017 Form 10-K |
Table of Contents
Table of Contents
| Glossary of Common Acronyms |
|
| 181 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 182 |
Table of Contents
Report of Independent Registered Public Accounting Firm
/s/ Deloitte & Touche LLP
New York, New York
February 27, 2018
| 183 | December 2017 Form 10-K |
Table of Contents
|
| December 2017 Form 10-K | 184 |
Table of Contents
|
| 185 | December 2017 Form 10-K |
Table of Contents
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
EXHIBITS TO FORM 10-K
For the year ended December 31, 2017
Commission File No. 1-11758
Table of Contents
|
Certain of the following exhibits, as indicated parenthetically, were previously filed as exhibits to registration statements filed by Morgan Stanley or its predecessor companies under the Securities Act or to reports or registration statements filed by Morgan Stanley or its predecessor companies under the Exchange Act and are hereby incorporated by reference to such statements or reports. Morgan Stanleys Exchange Act file number is 1-11758. The Exchange Act file number of Morgan Stanley Group Inc., a predecessor company (MSG), was 1-9085.(1)
|
Exhibit No. |
Description | |
| 3.1* | Amended and Restated Certificate of Incorporation of Morgan Stanley, as amended to date. | |
| 3.2 | ||
| 4.1 | Amended and Restated Senior Indenture dated as of May 1, 1999 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4-e to Morgan Stanleys Registration Statement on Form S-3/A (No. 333-75289) as amended by Fourth Supplemental Senior Indenture dated as of October 8, 2007 (Exhibit 4.3 to Morgan Stanleys Annual Report on Form 10-K for the fiscal year ended November 30, 2007). | |
| 4.2 | Senior Indenture dated as of November 1, 2004 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4-f to Morgan Stanleys Registration Statement on Form S-3/A (No. 333-117752), as amended by First Supplemental Senior Indenture dated as of September 4, 2007 (Exhibit 4.5 to Morgan Stanleys Annual Report on Form 10-K for the fiscal year ended November 30, 2007), Second Supplemental Senior Indenture dated as of January 4, 2008 (Exhibit 4.1 to Morgan Stanleys Current Report on Form 8-K dated January 4, 2008), Third Supplemental Senior Indenture dated as of September 10, 2008 (Exhibit 4 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended August 31, 2008), Fourth Supplemental Senior Indenture dated as of December 1, 2008 (Exhibit 4.1 to Morgan Stanleys Current Report on Form 8-K dated December 1, 2008), Fifth Supplemental Senior Indenture dated as of April 1, 2009 (Exhibit 4 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended March 31, 2009), Sixth Supplemental Senior Indenture dated as of September 16, 2011 (Exhibit 4.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended September 30, 2011), Seventh Supplemental Senior Indenture dated as of November 21, 2011 (Exhibit 4.4 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2011), Eighth Supplemental Senior Indenture dated as of May 4, 2012 (Exhibit 4.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended June 30, 2012), Ninth Supplemental Senior Indenture dated as of March 10, 2014 (Exhibit 4.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended March 31, 2014) and Tenth Supplemental Senior Indenture dated as of January 11, 2017 (Exhibit 4.1 to Morgan Stanleys Current Report on Form 8-K dated January 11, 2017). | |
| 4.3 | ||
| 4.4 | ||
| 4.5 | ||
| (1) | For purposes of this Exhibit Index, references to The Bank of New York mean in some instances the entity successor to JPMorgan Chase Bank, N.A. or J.P. Morgan Trust Company, National Association; references to JPMorgan Chase Bank, N.A. mean the entity formerly known as The Chase Manhattan Bank, in some instances as the successor to Chemical Bank; references to J.P. Morgan Trust Company, N.A. mean the entity formerly known as Bank One Trust Company, N.A., as successor to The First National Bank of Chicago. |
| E-1 | December 2017 Form 10-K |
Table of Contents
|
|
Exhibit No. |
Description | |
| 4.6 | ||
| 4.7 | ||
| 4.8 | ||
| 4.9 | ||
| 4.10 | ||
| 4.11 | ||
| 4.12 | ||
| 4.13 | ||
| 4.14 | ||
| 4.15 | ||
| 4.16 | ||
| 4.17 | ||
| 4.18 | ||
| 4.19 | ||
| 4.20 | ||
| 4.21 | ||
| 4.22 | ||
| December 2017 Form 10-K | E-2 |
Table of Contents
|
|
Exhibit No. |
Description | |
| 10.1 | ||
| 10.2 | Amended and Restated Investor Agreement dated as of June 30, 2011 by and between Morgan Stanley and Mitsubishi UFJ Financial Group, Inc. (Exhibit 10.1 to Morgan Stanleys Current Report on Form 8-K dated June 30, 2011), as amended by Third Amendment, dated October 3, 2013 (Exhibit 10.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended September 30, 2013) and Fourth Amendment, dated April 6, 2016 (Exhibit 10.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended March 31, 2016). | |
| 10.3 | Morgan Stanley 401(k) Plan, amended and restated as of January 1, 2013 (Exhibit 10.6 to Morgan Stanley Annual Report on Form 10-K for the year ended December 31, 2012), as amended by Amendment (Exhibit 10.5 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2013), Amendment (Exhibit 10.6 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2013), Amendment (Exhibit 10.5 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2014), Amendment (Exhibit 10.5 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2015) and Amendment (Exhibit 10.4 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2016). | |
| 10.4* | Amendment to Morgan Stanley 401(k) Plan, dated as of December 12, 2017. | |
| 10.5* | Amendment to Morgan Stanley 401(k) Plan, dated as of January 17, 2018. | |
| 10.6 | ||
| 10.7 | ||
| 10.8 | ||
| 10.9 | ||
| 10.10 | Morgan Stanley Supplemental Executive Retirement and Excess Plan, amended and restated effective December 31, 2008 (Exhibit 10.2 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended March 31, 2009) as amended by Amendment (Exhibit 10.5 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended June 30, 2009), Amendment (Exhibit 10.19 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2010), Amendment (Exhibit 10.3 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended June 30, 2011) and Amendment (Exhibit 10.1 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended September 30, 2014). | |
| 10.11 | 1995 Equity Incentive Compensation Plan (Annex A to MSGs Proxy Statement for its 1996 Annual Meeting of Stockholders) as amended by Amendment (Exhibit 10.39 to Morgan Stanleys Annual Report on Form 10-K for the fiscal year ended November 30, 2000), Amendment (Exhibit 10.5 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended August 31, 2005), Amendment (Exhibit 10.3 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended February 28, 2006), Amendment (Exhibit 10.24 to Morgan Stanleys Annual Report on Form 10-K for the fiscal year ended November 30, 2006) and Amendment (Exhibit 10.22 to Morgan Stanleys Annual Report on Form 10-K for the fiscal year ended November 30, 2007). | |
| 10.12 | ||
| 10.13 | ||
| 10.14 | ||
| E-3 | December 2017 Form 10-K |
Table of Contents
|
|
Exhibit No. |
Description | |
| 10.15 | ||
| 10.16 | ||
| 10.17 | Agreement between Morgan Stanley and James P. Gorman, dated August 16, 2005, and amendment dated December 17, 2008 (Exhibit 10.2 to Morgan Stanleys Quarterly Report on Form 10-Q for the quarter ended March 31, 2010), as amended by Amendment (Exhibit 10.25 to Morgan Stanleys Annual Report on Form 10-K for the year ended December 31, 2013). | |
| 10.18 | ||
| 10.19 | ||
| 10.20 | Equity Incentive Compensation Plan, as amended and restated as of March 30, 2017 (Exhibit 10.1 to Morgan Stanleys Current Report on Form 8-K dated May 22, 2017). | |
| 10.21 | ||
| 10.22 | ||
| 10.23 | ||
| 10.24 | ||
| 10.25 | ||
| 10.26 | ||
| 10.27 | ||
| 10.28 | ||
| 10.29 | ||
| 10.30 | ||
| 10.31 | ||
| 10.32 | ||
| 10.33* | Form of Award Certificate for Discretionary Retention Awards of Stock Units. | |
| 10.34* | ||
| December 2017 Form 10-K | E-4 |
Table of Contents
|
|
Exhibit No. |
Description | |
| 10.35* | Form of Award Certificate for Long-Term Incentive Program Awards. | |
| 10.36 | ||
| 10.37 | ||
| 12* | ||
| 21* | ||
| 23.1* | ||
| 24 | ||
| 31.1* | ||
| 31.2* | ||
| 32.1** | ||
| 32.2** | ||
| 101 | Interactive data files pursuant to Rule 405 of Regulation S-T: (i) the Consolidated Income StatementsTwelve Months Ended December 31, 2017, December 31, 2016, and December 31, 2015, (ii) the Consolidated Comprehensive Income StatementsTwelve Months Ended December 31, 2017, December 31, 2016 and December 31, 2015, (iii) the Consolidated Balance SheetsDecember 31, 2017 and December 31, 2016, (iv) the Consolidated Statements of Changes in Total EquityTwelve Months Ended December 31, 2017, December 31, 2016 and December 31, 2015, (v) the Consolidated Cash Flow StatementsTwelve Months Ended December 31, 2017, December 31, 2016 and December 31, 2015, and (vi) Notes to Consolidated Financial Statements. | |
| * | Filed herewith. |
| ** | Furnished herewith. |
| | Management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-K pursuant to Item 15(b). |
Note: Other instruments defining the rights of holders of long-term debt securities of Morgan Stanley and its subsidiaries are omitted pursuant to Section (b)(4)(iii) of Item 601 of Regulation S-K. Morgan Stanley hereby agrees to furnish copies of these instruments to the U.S. Securities and Exchange Commission upon request.
| E-5 | December 2017 Form 10-K |
Table of Contents
|
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 27, 2018.
| MORGAN STANLEY
(REGISTRANT) | ||
| By: |
/s/ JAMES P. GORMAN | |
| (James P. Gorman) | ||
| Chairman of the Board and Chief Executive Officer | ||
POWER OF ATTORNEY
We, the undersigned, hereby severally constitute Jonathan Pruzan, Eric F. Grossman and Martin M. Cohen, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, and in our names in the capacities indicated below, any and all amendments to the Annual Report on Form 10-K filed with the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys to any and all amendments to said Annual Report on Form 10-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on the 27th day of February, 2018.
| Signature |
Title | |||
| /s/ JAMES P. GORMAN (James P. Gorman) |
Chairman of the Board and Chief Executive Officer (Principal Executive Officer) | |||
| /s/ JONATHAN PRUZAN (Jonathan Pruzan) |
Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||
| /s/ PAUL C. WIRTH (Paul C. Wirth) |
Deputy Chief Financial Officer (Principal Accounting Officer) | |||
| /s/ ELIZABETH CORLEY (Elizabeth Corley) |
Director | |||
| /s/ ALISTAIR DARLING (Alistair Darling) |
Director | |||
| /s/ THOMAS H. GLOCER (Thomas H. Glocer) |
Director | |||
| /s/ ROBERT H. HERZ (Robert H. Herz) |
Director | |||
| /s/ NOBUYUKI HIRANO (Nobuyuki Hirano) |
Director | |||
| /s/ JAMI MISCIK (Jami Miscik) |
Director | |||
| S-1 | December 2017 Form 10-K |
Table of Contents
|
| Signature |
Title | |||
| /s/ DENNIS M. NALLY (Dennis M. Nally) |
Director | |||
| /s/ HUTHAM S. OLAYAN (Hutham S. Olayan) |
Director | |||
| /s/ JAMES W. OWENS (James W. Owens) |
Director | |||
| /s/ RYOSUKE TAMAKOSHI (Ryosuke Tamakoshi) |
Director | |||
| /s/ PERRY M. TRAQUINA (Perry M. Traquina) |
Director | |||
| /s/ RAYFORD WILKINS, JR. (Rayford Wilkins, Jr.) |
Director | |||
| December 2017 Form 10-K | S-2 |